chitosan has been researched along with Breast Neoplasms in 266 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (4.14) | 29.6817 |
| 2010's | 144 (54.14) | 24.3611 |
| 2020's | 111 (41.73) | 2.80 |
| Authors | Studies |
|---|---|
| Aboutalebi, F; Dormiani, K; Forouzanfar, M; Mirahmadi-Zare, SZ; Motiei, M; Nasr-Esfahani, MH | 1 |
| Basu, B; Ghosh, S; Kaur, H; Kumar, P; Nagpal, K | 1 |
| Dai, S; Hu, F; Liu, Y; Meng, T; Qiu, G; Wen, L; Yu, F; Yuan, H; Zhou, X; Zhu, Y | 1 |
| Bani, F; Gao, H; Kahroba, H; Nemati, M; Rahbarghazi, R; Rasmi, Y; Sadeghi, MR; Sepasi, T; Wang, Y; Zamiri, RE; Zarebkohan, A | 1 |
| Li, Z; Qi, Y; Qian, Z; Yuan, W | 1 |
| Abbaszadeh-Goudarzi, K; Ahmadi, M; Ansari Dezfouli, E; Chalajour, H; Ebrahimi, F; Gholizadeh Navashenaq, J; Hashemi, V; Hassannia, H; Hojjat-Farsangi, M; Izadi, S; Jadidi-Niaragh, F; Karoon Kiani, F; Karpisheh, V; Mahmoud Salehi Khesht, A; Mohammadi, M; Mortazavi Bulus, M; Nasr Esfahani, M; Shahmohammadi Farid, S; Soleimani, A | 1 |
| Agrawal, M; Alexander, A; Bhatt, T; Dubey, SK; Saha, RN; Saraf, S | 1 |
| Chen, X; Cui, Z; Gu, S; Huang, X; Liu, X; Mei, H; Nie, G; Teng, W; Wang, K; Xu, J; Zhang, Y | 1 |
| Katti, DS; Lohiya, G | 1 |
| Aghaabbasi, K; Aghaei Afshar, A; Azedi, F; Dadashzadeh, A; Dehshahri, A; Fatemi, I; Kesharwani, P; Madamsetty, VS; Moghassemi, S; Mohammadinejad, R; Pardakhty, A; Schneible, JD; Shirvani, A; Tavakol, S; Zarrabi, A | 1 |
| Du, D; Guo, X; Ji, J; Liao, J; Malichewe, C; Shang, P; Sun, C; Tang, YJ; Wang, L; Yang, X; Yao, Z | 1 |
| Bangde, P; Dandekar, P; Gaikwad, G; Jain, R; Pant, T | 1 |
| Bhaskaran Sathyabhama, A; Geethakumari, D; Mohandas, D; Raji Sathyan, K; Somasekharan, JV; Thavarool Puthiyedathu, S | 1 |
| Alhakamy, NA; Almoshari, Y; Alqahtani, SS; Alshahrani, S; Alshamrani, M; Bakkari, MA; Bukhary, HA; Ghazwani, M; Madkhali, OA; Mohan, S; Moni, SS; Salawi, A; Sultan, MH | 1 |
| Aiedeh, K; Al-Husein, BA; Alzoubi, KH; Matalqah, SM; Mhaidat, NM | 1 |
| Cha, BS; Chowdhury, P; Kim, S; Lee, ES; Park, KS; Woo, J; Yoon, T | 1 |
| Biswas, S; Ghosh, B; Itoo, AM; Paul, M | 1 |
| Burgara-Estrella, AJ; Diaz-Galvez, KR; Fernandez-Quiroz, D; Gallegos-Tabanico, A; Guzman-Partida, AM; Jimenez-Canale, J; Robles-Burgueño, MDR; Sarabia-Sainz, HM; Sarabia-Sainz, JA; Teran-Saavedra, NG; Vazquez-Moreno, L | 1 |
| Abdelnaby, E; Ezzat, AA; Hanafi, RS; Magdeldin, S; Mansour, S; Osama, A; Rashad, O; Tammam, SN | 1 |
| Carvalho, EC; Faustino, A; Freitas, LAP; Garbuio, DC; Hamamura, AC; Ribeiro, VDS; Viani, G | 1 |
| Alcantara, KP; Bulatao, BPI; Muangnoi, C; Nalinratana, N; Rojsitthisak, P; Sorasitthiyanukarn, FN; Truong, TH; Vajragupta, O | 1 |
| Akbuğa, J; Ekentok-Atıcı, C | 1 |
| Chen, Q; Cheng, X; Hu, T; Jia, C; Jiang, Z; Li, C; Xu, Y | 1 |
| Bekić, SS; Ćelić, AS; Ignjatović, NL; Kojić, V; Kuzminac, IZ; Savić, MP | 1 |
| Gao, M; He, X; Peng, H; Qiao, L; Shan, G; Yi, X; Zhang, R | 1 |
| Al-Kasim, MA; Alhazmi, A; Alothaid, H; Bantun, F; Habibullah, MM; Hakamy, A; Jamal, QMS; Kaabi, YA; Lohani, M; Makeen, HA; Mohan, S; Samlan, G; Syed, NK; Thangavel, N | 1 |
| Branco, PC; Costa-Lotufo, LV; Dartora, VFC; Lopes, LB; Passos, JS; Salata, GC; Silveira, E; Steiner, AA | 1 |
| Arabpour, J; Davodabadi, F; Díez-Pascual, AM; Rahdar, A; Sargazi, S; Sarhadi, M | 1 |
| El-Maraghy, SA; Motawi, TK; Nady, OM; Sabry, D; Senousy, MA | 1 |
| Ding, M; Guo, K; Liu, Y; Shubhra, QTH; Tang, Z; Wang, Z; Xiao, N; Zhang, B; Zhang, C | 1 |
| Bai, C; Feng, C; Li, W; Lou, J; Niu, S; Wang, T; Williams, GR; Zhang, Y; Zhu, LM | 1 |
| Akbuğa, J; Alan, S; Ekentok-Atıcı, C; Kabasakal, L; Özbaş, S; Özkan, N; Şalva, E | 1 |
| Li, L; Liu, T; Wen, M; Yang, X; Zhang, Y; Zheng, Z; Zhou, C; Zu, W | 1 |
| Tian, T | 1 |
| Abadi, PG; Banihashem, S; Bybordi, S; Faraji Dizaji, B; Farrokh-Eslamlou, N; Hasanbegloo, K; Irani, M; Jazi, FS | 1 |
| Amani, J; Asoodeh, A; Gheybi, E | 1 |
| Alves, CG; Correia, IJ; Costa, FJP; de Melo-Diogo, D; Lima-Sousa, R; Melo, BL; Nave, M | 1 |
| Dinari, M; Hadizadeh, M; Karimi, AR; Rostaminejad, B | 1 |
| Faramarzi, M; Panahi, M; Rahbari-Sisakht, M | 1 |
| Dai, F; Li, J; Lu, M; Ma, L; Qiu, T; Song, F; Tong, M; Zhang, X | 1 |
| Alioghli Ziaei, A; Amiryaghoubi, N; Erfan-Niya, H; Fathi, M | 1 |
| Al Aboody, MS; Alhoqail, WA; Alothaim, AS; Arulselvan, P; Eraqi, MM; Mickymaray, S; Suresh, K | 1 |
| Omrani, Z; Pourmadadi, M; Rashedi, H; Yazdian, F | 1 |
| Mazandarani, A; Mohammadnejad, J; Taravati, A; Yazdian, F | 1 |
| Patel, JK; Patil, PB | 1 |
| Es-Haghi, A; Homayouni Tabrizi, M; Mollaei, M | 1 |
| Jafari, H; Namazi, H | 1 |
| Cheng, YY; Hu, X; Jin, W; Li, W; Liu, W; Liu, Y; Lu, Y; Nie, Y; Pan, B; Shu, Y; Song, K; Su, Y; Zhang, J | 1 |
| Chen, Z; Geng, P; Jiang, R; Li, M; Li, X; Song, C; Wang, Z; Yin, S; Yu, N; Yu, W | 1 |
| De, A; Jaiswal, A; Kuppuswamy, G | 1 |
| Loconte, V; Soleimani, N; Vaseghi, A | 1 |
| Hou, G; Ji, L; Qian, J; Suo, A; Wang, J; Wang, Y; Xu, W; Yang, M | 2 |
| Kim, MW; Lee, R; Niidome, T | 1 |
| Duan, W; Ha-Lien Tran, P; Tran, TTD; Wang, T; Yang, C | 1 |
| Ardestani, SK; Behboudi, H; Kavoosi, G; Salehi, F | 1 |
| Ahmad, FJ; Ahmad, I; Akhter, S; Alam Rizvi, MM; Hafeez, Z; Jain, GK; Zafar, S | 1 |
| Chen, T; Jin, Y; Xiao, Z; Zhuang, B | 1 |
| Ahmadi, A; Atyabi, F; Baghaei, M; Baradaran, B; Edalati Fathabad, M; Farhadi, S; Ghalamfarsa, G; Ghasemi Chaleshtari, M; Haghnavaz, N; Hasanzadeh, S; Hojjat-Farsangi, M; Irandoust, M; Jadidi-Niaragh, F; Khazaei-Poul, Y; Masjedi, A; Sabz, G | 1 |
| Ganesh, GNK; Pindiprolu, SKSS; Sanapalli, BKR; Singh, MK; Yele, V | 1 |
| Chen, H; Cui, S; Du, J; Fan, X; Lan, H; Zhang, E; Zhang, S; Zhang, Z; Zhao, Y; Zhen, Y; Zhi, D | 1 |
| A, S; B S, L; E A K, N; Frank-Kamenetskaya, OV; J, RR; Martin, CA; Radhakrishnan, S; S, B; S, NK; V, N | 1 |
| Hu, FQ; Li, Y; Liu, X; Shang, XW; Wang, L; Yuan, H; Zhou, XQ | 1 |
| Abd Eldaim, MA; Abdallah, AEM; Abdel-Daim, MM; Abdelaziz, SAM; Abdul Rashid, S; Abdullah, AS; Abdullah, LC; Abramson, MJ; Ahmed, HB; Ahmed, MM; Ahn, YC; Alexander, DC; Ando, T; Angelone, AM; Anglani, F; Ap, Y; Arthanari, SK; Axelrad, C; Bai, S; Bakonyi, P; Barnes, E; Beckmann, NA; Bélafi-Bakó, K; Bennett, CM; Bestha, RM; Bitsch, RG; Bradley, CA; Bu, Y; Calò, LA; Cañedo-Villaroya, E; Carlson, L; Caruso, S; Casado-Flores, J; Ceol, M; Cesarino, I; Chen, IL; Chen, R; Chen, X; Chilvers, MI; Cho, WK; Choong, TSY; Conceição-Neto, N; Culver, EL; Dai, X; de Lama Caro-Patón, G; De Rosa, I; Del Prete, D; Dharmage, SC; Dimitriadis, E; Dittakavi, S; Dobrowolski, JC; Edin, S; Elgarawany, GE; Emam, HE; Emmens, RW; Erbas, B; Erwich, JJHM; Farghali, M; Feng, L; Funston, RN; Gabler, NK; Gale, P; Ganesh, M; Gao, J; Gao, L; Gao, X; García-Salido, A; Gatto, R; Gautam, S; Ge, C; Ghogomu, SM; Gianesello, L; Gonçales, VR; Gooch, JL; Gooding, JJ; Gourley, GG; Gu, H; Gu, X; Gu, Z; Guerreri, M; Guillén, M; Hazzaa, SM; Heylen, E; Hicks, R; Hong, X; Hoshi, M; Hu, B; Hu, LX; Hu, R; Hu, S; Huang, J; Huang, K; Hubbard, WB; Hui, J; Hwang, NY; Iannacci, J; Ianus, A; Iglesias-Bouzas, MI; Ihara, I; Iwasaki, M; Jaeger, S; Kandel, YR; Karpińska, G; Kim, HK; Klopfenstein, TJ; Knorr, D; Koók, L; Kotb, S; Kruithof, S; Larsson, P; Laurence, C; Leng, J; Li, H; Li, J; Li, Q; Li, S; Li, X; Li, Z; Lian, J; Liang, JX; Liang, X; Lighaam, LC; Lin, CW; Lin, HC; Lin, J; Ling, A; Liu, J; Liu, P; Liu, YS; Ljuslinder, I; Lo, GH; Lodge, CJ; Löfgren-Burström, A; Lowe, AJ; Lu, M; Lu, N; Lucero-Prisno, DE; Luebbe, KM; Luo, X; Ma, Z; Maes, P; Makuch, M; Malekbala, MR; Mao, Z; Martínez-Romera, I; Marzo, G; Mathew, FM; Mattei, A; Matthijnssens, J; Mayumi, M; Morita, N; Mueller, DS; Mullangi, R; Mummolo, S; Murthi, P; Myte, R; Nabeshima, T; Nakamoto, K; Nehdi, IA; Nemestóthy, N; Niessen, HWM; Noh, JM; Nota, A; Nunes, D; Oh, D; Öhlund, D; Olsen, KM; Ono, H; Osawa, Y; Palmqvist, R; Palombo, M; Park, M; Patience, JF; Peng, Y; Perng, DS; Persano, A; Priante, G; Prince, SJ; Pulipati, S; Pyo, H; Qiu, X; Quan, J; Quaranta, F; Quinzi, V; Rademacher, CJ; Rajaraman, G; Rashid, U; Rauch, JC; Rector, A; Remmerswaal, EBM; Ren, R; Rispens, T; Rocha, GS; Saad, NM; Saito, K; Salamova, A; Sarfaraz, K; Satoshi, A; Schnellmann, RG; Scholpa, NE; Schonhoff, M; Schwartz, KJ; Schwarze, M; Schweer, WP; Seiichi, Y; Serrano-González, A; Severino, J; Shemesh, N; Shi, ZQ; Shike, DW; Shim, YM; Siciliano, PA; Siebenrock, KA; Silva, MKL; Smith, DL; Soltani, S; Song, YM; Spry, ML; Stalker, LA; Stokes, RS; Sullivan, PG; Sun, JM; Sun, S; Svanes, C; Syo, K; Tai, CM; Takashima, S; Tashita, C; Taurino, A; Ten Berge, IJM; Tenuta, AU; Teo, SH; Tilley, RD; Trivedi, RK; Umetsu, K; Unger, PA; van Bruggen, R; van Ham, SM; Van Ranst, M; Vanitha, J; Vekaria, HJ; Venier, M; Venkateshwaran, K; Venkert, A; Vermeulen, E; Wan, C; Wang, H; Wang, N; Wang, P; Wang, T; Wang, X; Wang, Y; Wise, KA; Wolbink, GJ; Wu, J; Wu, P; Wu, S; Wu, Y; Xia, Q; Xin, W; Xiong, Q; Xu, H; Xu, P; Xue, S; Yamamoto, Y; Yamashiro, T; Yan, F; Yan, H; Yan, S; Yan, Y; Yang, JM; Yang, L; Yang, P; Ye, W; Yeh, JH; Yinda, CK; Ying, GG; Ying, L; Yoon, HG; Yu, H; Zainuddin, M; Zakkula, A; Zeller, M; Zeng, Y; Zha, J; Zhang, F; Zhang, H; Zhang, M; Zhang, Q; Zhang, S; Zhang, T; Zhang, Z; Zhao, C; Zhao, J; Zhao, Y; Zhong, Q; Zhu, J; Zingmark, C; Zo, JI; Zou, Y | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Arab-Tehrany, E; Barberi-Heyob, M; Belhaj, N; Elkhoury, K; Hasan, M; Kahn, C; Linder, M; Tamayol, A | 1 |
| Baby, T; Bulbule, A; Gorain, M; Kundu, GC; Radharani, NNV; Roy, G; Shetti, D; Yadav, AS | 1 |
| Aghaei Vanda, N; Atyabi, F; Baghaei, M; Farhadi, S; Ghalamfarsa, G; Haghnavaz, N; Jadidi-Niaragh, F; Kazemi, T; Khazaei-Poul, Y; Moghadaszadeh Ardebili, S; Namdar, A; Nikkhoo, A; Rostami, N; Sabz, G; Sadat Haeri, M; Yousefi, M | 1 |
| Alvi, SB; Jogdand, A; Rajalakshmi, PS; Rengan, AK | 1 |
| Ahmadi, A; Atyabi, F; Ghalamfarsa, G; Ghani, S; Hassannia, H; Heydarzadeh Asl, S; Hojjat-Farsangi, M; Irandoust, M; Jadidi-Niaragh, F; Karoon Kiani, F; Malakotikhah, F; Masjedi, A; Nabi Afjadi, M; Namdar, A | 1 |
| Franchi, GC; Gomes, AM; Martins, ML; Parra, JPRLL; Pinto, TS; Rodrigues, CG; Zambuzzi, WF | 1 |
| Mohammadi, Z; Rahmani, S; Samadi, FY | 1 |
| Alanazi, FK; Almanea, H; Alotaibi, AM; Alqahtani, AS; Badran, MM; Faris, T; Harisa, GI; Samy, AM | 1 |
| Bao, L; Shen, R; Wang, C; Yuan, H; Zhao, X | 1 |
| Dellali, KZ; Djennad, M; Gherghel, D; Ouagued, A; Popa, M; Rata, DM | 1 |
| Banjare, L; Jain, A; Jain, AK; Mishra, K; Ratre, P; Thareja, S; Verma, SK | 1 |
| Kurmi, BD; Paliwal, R; Paliwal, SR | 1 |
| Chen, H; Cheng, Y; Li, X; Shi, X; Tan, W; Tan, Z; Wang, J; Wang, X | 1 |
| Akbari-Fakhrabadi, A; Hameed, ASH; Karthikeyan, C; Sadiku, R; Varaprasad, K | 1 |
| Ahmadi, A; Boroumand-Noughabi, S; Hassannia, H; Heydari, M; Hojjat-Farsangi, M; Izadi, S; Jadidi-Niaragh, F; Karoon Kiani, F; Keramati, MR; Masjedi, A; Mohammadi, H; Sadat Eshaghi, F; Salimifard, S; Shahdadnejad, K | 1 |
| Hu, F; Li, Y; Tan, Y; Wen, L; Yu, F; Yuan, H; Zhu, Y | 1 |
| Moradi, A; Omidi, M; Pourmadadi, M; Yazdian, F; Zavareh, HS | 1 |
| Alizadeh, A; Alizadeh, M; Rezakhani, L | 1 |
| Ali, V; Ardestani, MS; Ebrahimi, SES; Farzaneh, J; Hadadian, S; Hamedani, MP; Hejazinia, H; Khalatbari, F; Monavvari, F; Seyedhamzeh, M; Shayegh, A; Zarazvand, F; Zonoubi, N | 1 |
| Jia, L; Li, Z; Zhao, Z; Zheng, D | 1 |
| Keyhanfar, M; Shakeran, Z; Sutherland, DS; Varshosaz, J | 1 |
| Afsari Kashani, M; Ahmadi, M; Ahmadpour Saheb, N; Aksoun, M; Aravindhan, S; Bastaki, S; Beigi Dargani, F; Dolati, S; Evgenievich Dorofeev, A; Jadidi-Niaragh, F; Jahandideh, H; Karoon Kiani, F; Mahmoodpoor, A; Masjedi, A; Namvar Aghdash, S; Nikkhoo, A | 1 |
| Chen-Yang, Z; Hui, MA; Li-Chun, C; Ming-Kun, S; Qing, F; Ren Bao Li Gao, A; Xiang-Yang, L; Zhen-Long, YU | 1 |
| Mohammadi, S; Salimi, A | 1 |
| Deng, T; Li, J; Xie, M; Yang, M; Yang, N | 1 |
| Afzali, E; Ansari, M; Eslaminejad, T; Shahrokhi-Farjah, M; Yazdi Rouholamini, SE | 1 |
| Abasalta, M; Asefnejad, A; Khorasani, MT; Saadatabadi, AR | 1 |
| Daneri-Navarro, A; Escareño, N; Hassan, N; Juárez, J; Kogan, MJ; Topete, A | 1 |
| Ahmadi, A; Ahmadi, M; Alian, F; Asl, SH; Beyzai, B; Budi, HS; Eshaghi, FS; Ghaderpour, A; Hassannia, H; Izadi, S; Jadidi-Niaragh, F; Mousavi, SM; Nikkhoo, A; Rafiee, B; Sojoodi, M; Timoshin, A | 1 |
| Cao, R; Chen, W; Gan, Z; Li, H; Qin, J; Su, W; Wang, P; Xie, Y; Xu, Y; Zhang, X | 1 |
| Chen, X; Fu, Z; Gao, F; Lu, S; Niu, S; Williams, GR; Wu, J; Zhang, X; Zhu, LM | 1 |
| Huang, TW; Yen, CH; Young, TH | 1 |
| Costa, BM; Gonçalves, CS; Martins, A; Martins, EP; Neves, NM; Oliveira, C; Reis, RL; Silva, TH | 1 |
| Cassano, R; Curcio, F; Pellegrino, M; Poerio, T; Russo, R; Trombino, S | 1 |
| Beverung, S; Florczyk, SJ; Le, MN; Steward, RL; Wang, Z; Xu, K | 1 |
| Mehrgardi, MA; Saberi, RS; Shafiei, F | 1 |
| El-Kemary, MA; Hanafy, NAN; Leporatti, S | 1 |
| Fatoorehchi, H; Nematollahi, E; Nigjeh, MN; Pourmadadi, M; Rashedi, H; Yazdian, F | 1 |
| Li, H; Rong, J; Yang, Y; Zhao, J; Zhou, F; Zhuang, S | 1 |
| Hanafy, NAN | 1 |
| Chen, H; Chen, J; Jiang, B; Kuang, Y; Li, C; Liao, T; Liu, C; Ren, J; Sun, Z | 1 |
| Abdel-Hakeem, MA; Badawy, I; Hassan, B; Mongy, S; Tantawi, OI | 1 |
| Elshishiny, F; Helmi, O; Mamdouh, W | 1 |
| Du, G; Li, R; Parseh, B; Wang, G | 1 |
| Nandgude, T; Pagar, R | 1 |
| Althobaiti, F; Elsayed, AM; Hanafy, NAN; Hassan, NS; Sahyon, HA; Sherif, NM | 1 |
| Guo, M; Hou, G; Qian, J; Sun, T; Suo, A; Wang, J; Xu, W; Zhang, Y | 1 |
| Arab-Bafrani, Z; Babaei, A; Jafari, SM; Khalili, M; Khoshbin-Khoshnazar, A; Mousavi, E; Zabihi, E | 1 |
| Alipanah, H; Farjam, M; Osanloo, M; Roozitalab, G; Zarenezhad, E | 1 |
| Aghebati-Maleki, L; Hassannia, H; Hojjat-Farsangi, M; Jadidi-Niaragh, F; Jafari, R; Karpisheh, V; Mahmoodpoor, A; Majidi Zolbanin, N; Melnikova, LA; Mohammadi, M; Olegovna Zekiy, A; Sahami Gilan, P; Salehi Khesht, AM | 1 |
| Babu, D; Gautam, M; Karuppaiah, A; Natrajan, T; Nesamony, J; Rajan, R; Ranganathan, H; Sankar, V; Selvaraj, D; Siram, K | 1 |
| Arafa, KK; El-Sherbiny, IM; Smyth, HDC | 1 |
| Abbasalizadeh, F; Akbarzadeh, A; Alizadeh, E; Bagher Fazljou, SM; Torbati, M | 1 |
| Cao, Y; Li, D; Li, F; Liu, P; Ma, J; Yang, H; Zhao, J | 1 |
| Chelladurai, S; Natesan, S; Palanichamy, R; Ponnusamy, C; Shanmugam Palaniappan, S; Sugumaran, A | 1 |
| Chen, Y; Gao, Z; Li, X; Liu, G; Yu, S | 1 |
| Amanpour, S; Bagheri-Khoulenjani, S; Esfandiarpour-Boroujeni, S; Mirzadeh, H | 1 |
| Fan, B; Gao, Z; Huang, W; Jin, H; Jin, M; Kang, L; Sun, P; Wang, QM | 1 |
| Hakamivala, A; Kashanian, S; Maharat, Z; Moghassemi, S; Omidfar, K; Yazdi Rouholamini, SE | 1 |
| Bindhani, BK; Kundu, CN; Nayak, A; Nayak, D; Siddharth, S | 1 |
| Kandasamy, R; Natesan, S; Palanichamy, R; Ponnusamy, C; Sugumaran, A; Thiagarajan, V | 1 |
| Asghar, S; Chen, Z; Gao, S; Huang, L; Ping, Q; Xiao, Y; Xu, Y; Yin, L | 1 |
| Chakraborty, S; Chauhan, D; De, A; George, L; Kaur, N; Mathur, P; Rengan, AK; Shanavas, A; Srivastava, R; Tejaswini, A; Vats, M; Yadav, P | 1 |
| Balaraman Ravindrran, M; Dhanapal, J | 1 |
| Du, L; Lin, L; Shi, X; Wang, M; Xiao, Y; Zhu, X | 1 |
| Bhunchu, S; Muangnoi, C; Rojsitthisak, P | 1 |
| Akinyelu, J; Singh, M | 1 |
| Bessone, F; Cavalli, R; Cavallo, F; Giribaldi, G; Guiot, C; Gulino, GR; Khadjavi, A; Minero, VG; Panariti, A; Prato, M; Quaglino, E; Rivolta, I; Stura, I | 1 |
| Abdellatif, KRA; Abo El-Ela, FI; F, AG; Kharshoum, RM; Salem, HF | 1 |
| Chen, G; Huang, Y; Lu, W; Svirskis, D; Wen, J; Ying, M | 1 |
| Ahiwale, R; Bothiraja, C; Mahadik, K; Pawar, A; Poudel, I | 1 |
| Duan, H; Ji, X; Jiang, L; Qiu, J; Wang, T; Wang, Y | 1 |
| Ismail, H; Martien, R; Pertiwi, D; Sismindari, - | 1 |
| Tang, C; Yang, H; Yin, C | 1 |
| Li, F; Shen, H; Wang, D; Wang, X; Yang, Z; Yao, C; Ye, Y | 1 |
| Gautam, N; Kathle, PK; Kesavan, K | 1 |
| Fu, S; Guo, H; Liu, A; Wang, W; Wu, D; Yan, Z; Zhang, J; Zhao, Y | 1 |
| Aghebati-Maleki, L; Atyabi, F; Jadidi-Niaragh, F; Jafari, R; Majidi Zolbanin, N; Majidi, J; Rafatpanah, H; Shanehbandi, D; Soltani Zangbar, MS; Yousefi, M | 1 |
| Baksi, R; Borse, SP; Nivsarkar, M; Rana, R; Sharma, V; Singh, DP | 1 |
| de Oliveira Pedro, R; Goycoolea, FM; Hoffmann, S; Neumann, MG; Pereira, S; Schmitt, CC | 1 |
| Martins, A; Neves, NM; Oliveira, C; Reis, RL; Silva, TH | 1 |
| Alirezapour, B; Amiri, M; Maadi, E; Moassesi, ME; Novin, FB; Rovais, MRA | 1 |
| Agrawal, P; Bharti, S; Koch, B; Kumar Mehata, A; Kumari, L; Muthu, MS; Singh, P; Singh, S; Viswanadh, MK | 1 |
| Abazari, R; Ataei, F; Carpenter-Warren, CL; Mahjoub, AR; Mehdizadeh, K; Morsali, A; Slawin, AMZ | 1 |
| Hong, Y; Hu, F; Lu, B; Meng, T; Qiu, G; Wu, J; Yuan, H; Yuan, M | 1 |
| Abou El-Nour, MF; El-Aziz, AA; El-Husseiny, N; El-Sheikh, MA; Ibrahim, SA; Mohamed, MM; Taher, FA | 1 |
| Fernández Baldo, MA; Jiménez Castillo, MI; Lorente, JA; Messina, GA; Ortega, FG; Piguillem, SV; Raba, J; Rubilar, O; Serrano, MJ; Tortella, GR | 1 |
| Alami-Milani, M; Barar, J; Erfan-Niya, H; Fathi, M; Geranmayeh, MH; Omidi, Y | 1 |
| Chen, WR; Doughty, A; Li, X; Li, Y; Nordquist, RE; Wang, L; West, C; Zhou, F | 1 |
| Artetxe, B; Gutiérrez-Zorrilla, JM; Pérez-Álvarez, L; Ruiz-Rubio, L; Vilas-Vilela, JL; Vivanco, MD | 1 |
| Boloursaz, LA; Habibi Jouybari, M; Hosseini, S; Irani, M; Mahboobnia, K; Moradi, M | 1 |
| Chen, X; Niu, S; Williams, GR; Wu, J; Zhang, X; Zheng, H; Zhu, LM | 1 |
| Ahmadian, S; Jafary, H; Morovati, A | 1 |
| Grafmüller, A; Hall, CK; Lilova, RL; Menegatti, S; Schneible, JD; Singhal, A | 1 |
| Ahn, CH; Emelianov, S; Kim, K; Sun, IC | 1 |
| Akbuga, J; Kaban, K; Salva, E | 3 |
| Cai, Q; de Pace, RC; Fan, Z; Gao, W; Liu, X; Nie, S; Pan, X; Sun, M; Wang, S; Zhang, J | 1 |
| Aydemir Sezer, U; Deliloglu Gurhan, İ; Gulce İz, S; Hasirci, N; Ozerkan, T | 1 |
| Webster, TJ; Zhang, L | 1 |
| Kannan, S; Nipun Babu, V; Subramanian, KS; Thangam, R; Vivek, R | 1 |
| Chen, H; Li, J; Li, R; Wang, Y; Yang, X; Zhang, C; Zhou, P | 1 |
| Choi, K; Jeong, SY; Kim, K; Koo, H; Kwon, IC; Lee, SC; Min, KH; Park, JH; Park, K | 1 |
| Cho, HY; Choi, JW; Kim, TH; Ko, EB; Yea, CH | 1 |
| Correia, IJ; Costa, E; Gaspar, VM; Marques, JG; Paquete, CM | 1 |
| Chu, M; Guo, Y; Liu, H; Otieno, BO; Tan, S; Xu, C; Yang, X; Zhang, Z; Zhao, S | 1 |
| Akbuğa, J; Alan, S; Eren, F; Kabasakal, L; Özkan, N; Şalva, E; Turan, SO | 1 |
| Kannan, S; Nipunbabu, V; Ponraj, T; Thangam, R; Vivek, R | 1 |
| Eskridge, C; Kmiec, EB; Niamat, RA; Samuel, S; Sims-Mourtada, J | 1 |
| Chen, FD; Chen, JY; Chen, WR; Chen, YL; Chiu, SJ; Lee, YJ; Leu, JD; Lin, LT; Wang, BS; Wang, CY; Yang, FY | 1 |
| Ellenbogen, RG; Erickson, AE; Kievit, FM; Tsao, CT; Wang, K; Zhang, M | 1 |
| Alexander, A; Khan, J; Saraf, S | 1 |
| Fang, J; Jiang, Y; Liu, Y; Luo, Y; Ma, P; Meng, F; Sui, C; Tian, X; Xu, K; Yin, H; Zhang, S | 1 |
| Emami, J; Hasanzadeh, F; Lavasanifar, A; Minaiyan, M; Mostafavi, A; Rezazadeh, M; Rostami, M; Sadeghi, H | 1 |
| Bai, H; Cai, J; Luo, J; Yang, P; Zhang, S | 1 |
| Castro, NJ; Fu, SW; Fu, Y; Wang, M; Zhang, LG; Zhu, W | 1 |
| Liu, CH; Liu, P; Zhi, XT; Zou, Y | 1 |
| Asgarshamsi, M; Fattahi, A; Hasanzadeh, F; Mirian, M; Rostami, M; Sadeghi-aliabadi, H; Varshosaz, J | 1 |
| Kim, JO; Nguyen, CN; Nguyen, HT; Nguyen, TD; Poudel, BK; Tran, TH; Yong, CS | 1 |
| Ge, Y; Li, L; Zhao, Y | 1 |
| Cheng, J; Liu, Q; Rauth, AM; Shuhendler, AJ; Wu, XY | 1 |
| Fales, A; Gandra, N; Nergiz, SZ; Portz, C; Singamaneni, S; Vo-Dinh, T | 1 |
| Atyabi, F; Jalilian, AR; Johari-Daha, F; Mollarazi, E | 1 |
| Shen, Q; Xu, Q; Yi, C; Zhu, T | 1 |
| Hou, L; Huang, H; Zhang, H; Zhang, Y; Zhang, Z; Zhu, X | 2 |
| Aaldering, LJ; Götte, M; Goycoolea, FM; Moerschbacher, BM; Pereira, S; Ritzefeld, M; Santos-Carballal, B; Sewald, N | 1 |
| Kumar, P; Srivastava, R | 1 |
| Jheng, PR; Lu, KY; Mi, FL; Yu, SH | 1 |
| Chen, Y; Hong, H; Li, Y; Liu, C; Qian, J; Wang, G; Wang, P; Wang, Y; Yu, B; Yuan, Y | 1 |
| Cai, X; Chen, H; Jia, Y; Lv, F; Nan, W; Qin, J; Xie, LQ; Yang, W; Zhang, QQ | 1 |
| Kanwar, JR; Kanwar, RK; Patel, YS; Rajkhowa, R; Roy, K; Wang, X | 1 |
| Atyabi, F; Hadjati, J; Hassannia, H; Jadidi-Niaragh, F; Kheshtchin, N; Kiani, M; Mollarazi, E; Rastegari, A; Razavi, A; Shokri, F; Yousefi, M | 1 |
| Akbal, Ö; Denkbaş, EB; Erdal, E; Kavaz, D; Vural, T | 1 |
| Gunduz, U; Unsoy, G | 1 |
| Abdolalizadeh, J; Aghebati Maleki, L; Atyabi, F; Eivazy, P; Jadidi-Niaragh, F; Miahipour, A; Yousefi, M | 1 |
| Ismail, H; Martien, R; Name, S; Wicaksono, PA | 1 |
| Cao, J; Chen, D; Deng, D; Gu, Y; Huang, S; Tang, L | 1 |
| Aghebati Maleki, L; Akbarzadeh, P; Alinejad, V; Atyabi, F; Baradaran, B; Hossein Somi, M; Kazerooni, H; Samadi Kafil, H; Siah Mansouri, H; Yousefi, M | 1 |
| Atyabi, F; Atyabi, SM; Dinarvand, M; Dinarvand, R; Irani, S; Mirfakhraie, R; Mirzaie, ZH; Varshochian, R | 1 |
| Agrawal, S; Ahmad, H; Arya, A; Dwivedi, AK; Dwivedi, M; Lal, J; Sharma, K; Shukla, M | 1 |
| Bai, H; Cai, J; Chen, ZW; Huang, L; Jiang, J; Jin, H; Li, L; Li, T; Pi, J; Shao, M; Wang, X; Yang, F; Yang, P; Zhu, H | 1 |
| Chattopadhyay, S; Das, DK; Dash, SK; Karmakar, P; Laha, D; Pramanik, A; Pramanik, P; Roy, S | 1 |
| Chitkara, D; Kumar, P; Kumar, R; Raza, K; Singh, B; Thakur, CK; Thotakura, N | 1 |
| He, RR; Li, YF; Liu, M; Shen, Y; Wu, Y; Yang, J; Zhou, C | 1 |
| Cheng, B; Hu, F; Hu, Y; Liu, J; Liu, X; Meng, T; Wen, L; Yuan, H; Yuan, M; Zhu, Y | 1 |
| Aliabadi, HS; Behdadfar, B; Hassanzadeh, F; Khoraskani, FR; Mirian, M; Varshosaz, J | 1 |
| Hondermarck, H; Liang, M; Shargh, VH | 1 |
| Cheng, B; Hu, F; Hu, Y; Liu, N; Tan, Y; Wen, L; Yuan, H | 1 |
| Abdul Murad, NA; Amin, MC; Butt, AM; Jamal, R; Katas, H; Kesharwani, P | 1 |
| Atyabi, F; Dinarvand, R; Ebrahimi, SM; Esfandyari-Manesh, M; Ghahremani, MH; Mohammadi, A; Nabavi, SM; Shahmoradi, E; Varnamkhasti, BS | 1 |
| Ajami, M; Arab, S; Atyabi, F; Habibi, S; Hadjati, J; Hassannia, H; Jadidi-Niaragh, F; Kheshtchin, N; Masoumi, F; Mirsanei, Z; Noorbakhsh, F; Rastegari, A; Shokri, F | 1 |
| Khan, MA; Mehdi, SH; Quadri, J; Rizvi, MM; Zafaryab, M | 1 |
| Campos, J; Haidar, ZS; Varas-Godoy, M | 1 |
| Chourasia, MK; Gothwal, A; Gupta, U; Khan, I; Kumar, V; Sharma, AK; Sharma, S; Singh, Y | 1 |
| Kim, JH; Kim, K; Koo, H; Kwon, IC; Lee, H; Lee, KY; Lee, S; Na, JH; Shim, MK; Shin, ML; Yoon, HY | 1 |
| Chand, M; Jena, SK; Kaur, S; Samal, SK; Sangamwar, AT | 1 |
| Cao, W; Nanayakkara, IA; White, IM | 1 |
| Cheng, B; Hu, F; Huang, X; Liu, N; Liu, X; Lu, B; Meng, T; Tan, Y; Yuan, H; Zhu, Y | 1 |
| Gong, S; Tiwari, A | 1 |
| Nam, KS; Shon, YH | 1 |
| Chen, L; Gao, Y; Gu, W; Li, Y; Zhang, Z | 1 |
| Bosman, F; Buchegger, F; Doelker, E; Faes, A; Hofmann, H; Jordan, O; Le Renard, PE; Petri-Fink, A; Rüfenacht, D | 1 |
| Baggio, G; Bruni, E; Coppi, G; Iannuccelli, V; Rossi, T | 1 |
| He, C; He, X; Tan, W; Wang, K; Wu, P; Zheng, M | 1 |
| Bolden, G; Chinta, DM; Dash, S; Graves, RA; Hazari, S; Kishore, V; Mandal, TK; Pamujula, S | 1 |
| Akbuğa, J; Salva, E | 1 |
| Bar-Eli, M; Han, HD; Lee, SJ; Lopez-Berestein, G; Mora, EM; Nishimura, M; Roh, JW; Sood, AK; Stone, RL | 1 |
| Adalsteinsson, O; Chen, WR; Ferrel, GL; Guerra, MC; Hode, T; Li, X; Liu, H; Lunn, JA; Nordquist, RE | 1 |
| Maharramov, A; Ramazanov, MA; Saboktakin, MR; Tabatabaie, RM | 1 |
| Andreeva, ER; Bartkowiak, A; Bezdetnaya, LN; Goergen, JL; Guillemin, F; Markvicheva, EA; Udartseva, OO; Zaytseva-Zotova, DS | 1 |
| Deshpande, PB; Karthik, A; Kumar, AR; Nayak, UY; Reddy, MS; Shavi, GV; Udupa, N | 1 |
| Jeong, HJ; Kim, J; Lee, CM; Lee, KY | 1 |
| Khar, RK; Mishra, PR; Singodia, D; Talegaonkar, S | 1 |
| Chu, PK; Deng, Z; Hu, X; Wu, S; Xu, Z; Zhen, Z | 1 |
| Crepin, M; Huang, S; Jiang, M; Ouyang, H; Pi, Z; Ruan, P; Yi, P; Zhao, H | 1 |
| Aseh, A; Chang, D; Choi, B; Gupta, V; Mathur, AB; Mildred, L; Mun, GH; Patel, A; Price, JE; Robb, G; Zhang, Q | 1 |
| Faneca, H; Figueiredo, MM; Gil, MH; Lima, MP; Moura, MJ | 1 |
| Ding, D; Li, K; Liu, B; Pu, KY | 1 |
| Chen, JF; Tao, X; Teng, Y; Wang, LX; Wang, XL; Zeng, Y; Zheng, YZ | 1 |
| Atyabi, F; Azizi, E; Dinarvand, R; Talaei, F | 1 |
| Atyabi, F; Dinarvand, R; Movahedi, AA; Vasheghani-Farahani, E; Yousefpour, P | 1 |
| Kong, F; Liang, D; Liu, G; Sun, B; Zhao, R; Zhou, S; Zuo, A | 1 |
| Cui, F; Fang, L; Li, X; Liang, N; Piao, H; Sun, S | 1 |
| Guo, X; Li, N; Liu, X; Ma, X; Yu, W; Zhang, Y; Zhou, H | 1 |
| Cao, W; He, ZG; Lian, H; Liu, YH; Sun, J; Sun, YH; Wang, SL; Wang, YJ; Yu, YP | 1 |
| Chen, Y; Deng, X; Duan, J; Mansour, HM; Pan, Y; Wang, J; Zhang, Y; Zhao, J | 1 |
| Chen, Y; Duan, C; Hao, L; Jia, L; Liu, G; Liu, Y; Wang, F; Zhang, D; Zhang, Q; Zheng, D | 1 |
| Arami, H; Disis, ML; Ellenbogen, RG; Kievit, FM; Lai, VP; Park, JO; Stephen, ZR; Veiseh, O; Wang, T; Zhang, M | 1 |
| Anitha, A; Chennazhi, KP; Jayakumar, R; Nair, SV | 1 |
| Jeong, SY; Kim, S; Kwon, IC; Lim, CK; Shin, J | 1 |
| Fei, XN; Li, C; Liu, Y | 1 |
| Chen, Y; Huo, M; Wang, J; Zhang, Q; Zhang, Y; Zhou, J; Zou, A | 1 |
| Lin, H; Qu, D; Xue, J; Zhang, C; Zhang, N | 1 |
| Dhiman, HK; Panda, AK; Ray, AR | 2 |
| Lu, B; Xiong, SB; Yang, H; Yin, XD; Zhao, RB | 1 |
| Bertrand, JR; Blot, E; Li, H; Lu, H; Maksimenko, A; Malvy, C; Opolon, P; Pillé, JY; Pritchard, LL; Soria, C; Soria, J; Vannier, JP | 1 |
| Oungbho, K; Tangtrakulwanich, B; Vechasilp, J; Yuenyongsawad, S | 1 |
| Dash, AK; Nagvekar, AA; Trickler, WJ | 1 |
7 review(s) available for chitosan and Breast Neoplasms
| Article | Year |
|---|---|
Application of chitosan modified nanocarriers in breast cancer.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Chitosan; Drug Carriers; Female; Humans; Nanoparticles | 2022 |
Chitosan: A versatile bio-platform for breast cancer theranostics.
Topics: Breast Neoplasms; Chitosan; Drug Carriers; Drug Delivery Systems; Female; Humans; Precision Medicine; United States | 2022 |
Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches.
Topics: Adjuvants, Immunologic; Breast Neoplasms; Calcium; Cancer Vaccines; Chitosan; Female; Hormones; Humans; Lipids; Peptides; Phosphates; Selenium; Silicon; Vaccines; Vaccines, DNA; Vaccines, Subunit | 2022 |
Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Amylose; Anaerobiosis; Animals; Anti-Bacterial Agents; Anura; Arginase; Arthritis, Rheumatoid; Asthma; Atmosphere; B-Lymphocytes; Basic Helix-Loop-Helix Transcription Factors; Bioelectric Energy Sources; Biofilms; Biofuels; Biomarkers; Biopolymers; Bioreactors; Brain; Brain Injuries, Traumatic; Breast Neoplasms; Calibration; Carbon Tetrachloride; Caspase 3; Catalysis; Catechin; Cations; Cattle; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Body; Cell Line, Tumor; Cell Plasticity; Chemical and Drug Induced Liver Injury; Chemistry Techniques, Synthetic; China; Chitosan; Chloride Channels; Chromatography, High Pressure Liquid; Chromosome Mapping; Cognition; Cognitive Dysfunction; Cohort Studies; Colitis, Ulcerative; Colloids; Coloring Agents; Congresses as Topic; Correlation of Data; Crystallization; Cyanoacrylates; Cyclohexane Monoterpenes; Cyprinidae; Cytochrome P-450 CYP1A1; Death, Sudden; Dent Disease; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Disease Progression; Disease Resistance; Disulfides; Drug Monitoring; Drug Stability; Ecotoxicology; Electricity; Electrodes; Endocytosis; Environmental Exposure; Environmental Monitoring; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Esophageal and Gastric Varices; Esters; Fagopyrum; Female; Ferrosoferric Oxide; Flame Retardants; Flavobacteriaceae; Flow Cytometry; Follow-Up Studies; Formoterol Fumarate; Fusarium; Garlic; Gastrointestinal Hemorrhage; Gene Expression; Genes, Plant; Genetic Markers; Glial Fibrillary Acidic Protein; Gliosis; Global Health; Glutathione Transferase; Glycine max; Gum Arabic; Hemostasis, Endoscopic; Hepatocytes; Hippocampus; Humans; Hydrogen-Ion Concentration; Illinois; Immunoglobulin G; Indoleamine-Pyrrole 2,3,-Dioxygenase; Infant, Newborn; Infant, Small for Gestational Age; Injections, Intraperitoneal; Interleukin-4; Iowa; Iron; Ki-67 Antigen; Kidney; Kinetics; Kynurenine; Lakes; Levofloxacin; Lipid Peroxidation; Lipids; Liver; Liver Cirrhosis, Experimental; Magnetic Fields; Magnetic Iron Oxide Nanoparticles; Male; Manure; Maze Learning; Memory, Short-Term; Metal Nanoparticles; Metals, Heavy; Methane; Mice; Mice, Inbred C57BL; Mice, Knockout; Michigan; Microalgae; Microbial Consortia; Mitochondria; Models, Animal; Models, Chemical; Models, Neurological; Molecular Structure; Molecular Weight; Mutation; Myeloid-Derived Suppressor Cells; NADPH Oxidase 2; Neoplasm Recurrence, Local; Neurites; Neurons; Neuroprotective Agents; NF-kappa B; NIH 3T3 Cells; Nitric Oxide Synthase Type II; Nitrogen; Ohio; Ointments; Ontario; Organelle Biogenesis; Organophosphates; Organophosphorus Compounds; Oxidative Stress; Palladium; Particle Size; Pectins; Phenotype; Phytotherapy; Piperidines; Placenta; Plant Diseases; Plant Extracts; Polymers; Polymorphism, Genetic; Polyphenols; Powders; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Protein Kinase Inhibitors; Protein Structure, Secondary; Proteins; Pyridines; Pyrimidines; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Aryl Hydrocarbon; Receptors, Chemokine; Receptors, Formyl Peptide; Receptors, Lipoxin; Recovery of Function; Recurrence; Reference Standards; Reference Values; Reproducibility of Results; Respiratory Function Tests; Retrospective Studies; Risk; Sensitivity and Specificity; Sewage; Signal Transduction; Sodium Glutamate; Soil; Solanum tuberosum; Solubility; Solutions; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spermatozoa; STAT3 Transcription Factor; Sulfamethoxazole; Tea; Temperature; Thermodynamics; Thrombin; Treatment Outcome; Triazoles; United States; Viscosity; Waste Disposal, Fluid; Wastewater; Water; Water Pollutants, Chemical; Water Purification; White Matter; Wisconsin; X-Ray Diffraction; Zea mays | 2013 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Prospects and challenges of anticancer agents' delivery via chitosan-based drug carriers to combat breast cancer: a review.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Carriers; Humans; Nanoparticles; Signal Transduction | 2021 |
Plausible role of chitosan in drug and gene delivery against resistant breast cancer cells.
Topics: Breast Neoplasms; Chitosan; Drug Carriers; Drug Liberation; Humans; MCF-7 Cells | 2021 |
3 trial(s) available for chitosan and Breast Neoplasms
| Article | Year |
|---|---|
A Chitosan-Coated Chamomile Microparticles Formulation to Prevent Radiodermatitis in Breast: A Double-blinded, Controlled, Randomized, Phase II Clinical Trial.
Topics: Breast Neoplasms; Chamomile; Chitosan; Female; Humans; Plant Extracts; Radiodermatitis | 2022 |
Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Amylose; Anaerobiosis; Animals; Anti-Bacterial Agents; Anura; Arginase; Arthritis, Rheumatoid; Asthma; Atmosphere; B-Lymphocytes; Basic Helix-Loop-Helix Transcription Factors; Bioelectric Energy Sources; Biofilms; Biofuels; Biomarkers; Biopolymers; Bioreactors; Brain; Brain Injuries, Traumatic; Breast Neoplasms; Calibration; Carbon Tetrachloride; Caspase 3; Catalysis; Catechin; Cations; Cattle; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Body; Cell Line, Tumor; Cell Plasticity; Chemical and Drug Induced Liver Injury; Chemistry Techniques, Synthetic; China; Chitosan; Chloride Channels; Chromatography, High Pressure Liquid; Chromosome Mapping; Cognition; Cognitive Dysfunction; Cohort Studies; Colitis, Ulcerative; Colloids; Coloring Agents; Congresses as Topic; Correlation of Data; Crystallization; Cyanoacrylates; Cyclohexane Monoterpenes; Cyprinidae; Cytochrome P-450 CYP1A1; Death, Sudden; Dent Disease; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Disease Progression; Disease Resistance; Disulfides; Drug Monitoring; Drug Stability; Ecotoxicology; Electricity; Electrodes; Endocytosis; Environmental Exposure; Environmental Monitoring; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Esophageal and Gastric Varices; Esters; Fagopyrum; Female; Ferrosoferric Oxide; Flame Retardants; Flavobacteriaceae; Flow Cytometry; Follow-Up Studies; Formoterol Fumarate; Fusarium; Garlic; Gastrointestinal Hemorrhage; Gene Expression; Genes, Plant; Genetic Markers; Glial Fibrillary Acidic Protein; Gliosis; Global Health; Glutathione Transferase; Glycine max; Gum Arabic; Hemostasis, Endoscopic; Hepatocytes; Hippocampus; Humans; Hydrogen-Ion Concentration; Illinois; Immunoglobulin G; Indoleamine-Pyrrole 2,3,-Dioxygenase; Infant, Newborn; Infant, Small for Gestational Age; Injections, Intraperitoneal; Interleukin-4; Iowa; Iron; Ki-67 Antigen; Kidney; Kinetics; Kynurenine; Lakes; Levofloxacin; Lipid Peroxidation; Lipids; Liver; Liver Cirrhosis, Experimental; Magnetic Fields; Magnetic Iron Oxide Nanoparticles; Male; Manure; Maze Learning; Memory, Short-Term; Metal Nanoparticles; Metals, Heavy; Methane; Mice; Mice, Inbred C57BL; Mice, Knockout; Michigan; Microalgae; Microbial Consortia; Mitochondria; Models, Animal; Models, Chemical; Models, Neurological; Molecular Structure; Molecular Weight; Mutation; Myeloid-Derived Suppressor Cells; NADPH Oxidase 2; Neoplasm Recurrence, Local; Neurites; Neurons; Neuroprotective Agents; NF-kappa B; NIH 3T3 Cells; Nitric Oxide Synthase Type II; Nitrogen; Ohio; Ointments; Ontario; Organelle Biogenesis; Organophosphates; Organophosphorus Compounds; Oxidative Stress; Palladium; Particle Size; Pectins; Phenotype; Phytotherapy; Piperidines; Placenta; Plant Diseases; Plant Extracts; Polymers; Polymorphism, Genetic; Polyphenols; Powders; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Protein Kinase Inhibitors; Protein Structure, Secondary; Proteins; Pyridines; Pyrimidines; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Aryl Hydrocarbon; Receptors, Chemokine; Receptors, Formyl Peptide; Receptors, Lipoxin; Recovery of Function; Recurrence; Reference Standards; Reference Values; Reproducibility of Results; Respiratory Function Tests; Retrospective Studies; Risk; Sensitivity and Specificity; Sewage; Signal Transduction; Sodium Glutamate; Soil; Solanum tuberosum; Solubility; Solutions; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spermatozoa; STAT3 Transcription Factor; Sulfamethoxazole; Tea; Temperature; Thermodynamics; Thrombin; Treatment Outcome; Triazoles; United States; Viscosity; Waste Disposal, Fluid; Wastewater; Water; Water Pollutants, Chemical; Water Purification; White Matter; Wisconsin; X-Ray Diffraction; Zea mays | 2013 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
258 other study(ies) available for chitosan and Breast Neoplasms
| Article | Year |
|---|---|
Smart co-delivery of miR-34a and cytotoxic peptides (LTX-315 and melittin) by chitosan based polyelectrolyte nanocarriers for specific cancer cell death induction.
Topics: Breast Neoplasms; Cell Death; Cell Line, Tumor; Chitosan; Female; Humans; Melitten; MicroRNAs; Nanoparticles; Oligopeptides; Polyelectrolytes | 2021 |
Ellagic acid-loaded, tween 80-coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: In-vitro and in-vivo study.
Topics: Animals; Breast Neoplasms; Calorimetry, Differential Scanning; Cell Death; Cell Survival; Chitosan; Computer Simulation; Drug Liberation; Ellagic Acid; Female; HEK293 Cells; Humans; MCF-7 Cells; Mice; Nanoparticles; Particle Size; Polysorbates; Static Electricity; Tumor Burden | 2021 |
All-Trans Retinoic Acid and Doxorubicin Delivery by Folic Acid Modified Polymeric Micelles for the Modulation of Pin1-Mediated DOX-Induced Breast Cancer Stemness and Metastasis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Chitosan; Disease Models, Animal; Doxorubicin; Drug Liberation; Drug Synergism; Female; Folic Acid; Gene Knockdown Techniques; Humans; Mice; Micelles; Nanoparticle Drug Delivery System; Neoplastic Stem Cells; NIMA-Interacting Peptidylprolyl Isomerase; Tissue Distribution; Tretinoin | 2021 |
Unraveling the Effect of Breast Cancer Patients' Plasma on the Targeting Ability of Folic Acid-Modified Chitosan Nanoparticles.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Folic Acid; Humans; Macrophages; Nanoparticles | 2021 |
Injectable and self-healing nanocomposite hydrogel loading needle-like nano-hydroxyapatite and graphene oxide for synergistic tumour proliferation inhibition and photothermal therapy.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Durapatite; Graphite; Hydrogels; Infrared Rays; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanocomposites; NIH 3T3 Cells; Photothermal Therapy; Polyethylene Glycols | 2021 |
Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Proliferation; Chitosan; Colorectal Neoplasms; Combined Modality Therapy; Dendritic Cells; Female; Humans; Immunotherapy; Lactic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Programmed Cell Death 1 Receptor; Receptor, Adenosine A2A; RNA, Small Interfering; Tumor Cells, Cultured; Vaccines; Xenograft Model Antitumor Assays | 2022 |
Local delivery of biocompatible lentinan/chitosan composite for prolonged inhibition of postoperative breast cancer recurrence.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chitosan; Disease Models, Animal; Drug Delivery Systems; Female; Humans; Lentinan; Mice; Postoperative Care; Recurrence; Spectrum Analysis; Treatment Outcome; Xenograft Model Antitumor Assays | 2022 |
Carboxylated chitosan-mediated improved efficacy of mesoporous silica nanoparticle-based targeted drug delivery system for breast cancer therapy.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Cell Proliferation; Chitosan; Dose-Response Relationship, Drug; Doxorubicin; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Humans; Hydrogen-Ion Concentration; Molecular Structure; Nanoparticles; Particle Size; Porosity; Silicon Dioxide; Structure-Activity Relationship; Surface Properties | 2022 |
Hyaluronic Acid-Modified Nanoparticles Self-Assembled from Linoleic Acid-Conjugated Chitosan for the Codelivery of miR34a and Doxorubicin in Resistant Breast Cancer.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Proliferation; Chitosan; Doxorubicin; Drug Combinations; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Humans; Hyaluronic Acid; Linoleic Acid; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Nanoparticles; Neoplasm Transplantation | 2022 |
Trimethyl chitosan coated palladium nanoparticles as a photothermal agent and its in vitro evaluation in 2D and 3D model of breast cancer cells.
Topics: Administration, Oral; Breast Neoplasms; Chitosan; Female; Humans; Metal Nanoparticles; Nanoparticles; Palladium; Tumor Microenvironment | 2022 |
Folate functionalized chitosan nanoparticles as targeted delivery systems for improved anticancer efficiency of cytarabine in MCF-7 human breast cancer cell lines.
Topics: Breast Neoplasms; Cell Survival; Chitosan; Cytarabine; Drug Carriers; Drug Delivery Systems; Female; Folic Acid; Humans; MCF-7 Cells; Nanoparticles | 2022 |
Characterization of cisplatin-loaded chitosan nanoparticles and rituximab-linked surfaces as target-specific injectable nano-formulations for combating cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Chitosan; Cisplatin; Drug Carriers; Drug Compounding; Drug Delivery Systems; Humans; MCF-7 Cells; Nanoparticles; Particle Size; Rituximab | 2022 |
Preparation of Modified Chitosan-based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer Cells.
Topics: Breast Neoplasms; Chitosan; Cisplatin; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Humans; Hydrogen-Ion Concentration; Nanoparticles; Polymers | 2022 |
T7 Endonuclease I-mediated voltammetric detection of KRAS mutation coupled with horseradish peroxidase for signal amplification.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; Colonic Neoplasms; Deoxyribonuclease I; Electrochemical Techniques; Electrodes; Female; Gene Expression Regulation, Neoplastic; Gold; Horseradish Peroxidase; Humans; Ionic Liquids; Metal Nanoparticles; Mutation; Nanotubes, Carbon; Proto-Oncogene Proteins p21(ras); Signal Transduction | 2022 |
Oxaliplatin delivery via chitosan/vitamin E conjugate micelles for improved efficacy and MDR-reversal in breast cancer.
Topics: alpha-Tocopherol; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Erythrocytes; Female; Hemolysis; Humans; Male; Mice, Inbred BALB C; Micelles; Oxaliplatin; Rats, Wistar; Reactive Oxygen Species | 2022 |
Cytotoxic activity of Crotalus molossus molossus snake venom-loaded in chitosan nanoparticles against T-47D breast carcinoma cells.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chitosan; Crotalid Venoms; Crotalus; Drug Delivery Systems; Female; Humans; Male; Nanomedicine; Nanoparticles; Snake Venoms | 2022 |
Different Serum, Different Protein Corona! The Impact of the Serum Source on Cellular Targeting of Folic Acid-Modified Chitosan-Based Nanoparticles.
Topics: Breast Neoplasms; Chitosan; Female; Folic Acid; Humans; Nanoparticles; Protein Corona; Proteomics; Reproducibility of Results; Serum Albumin, Bovine | 2022 |
Chitosan-coated nanostructured lipid carriers for transdermal delivery of tetrahydrocurcumin for breast cancer therapy.
Topics: Breast Neoplasms; Chitosan; Curcumin; Drug Carriers; Female; Humans; Lipids; Nanostructures; Particle Size | 2022 |
Chitosan Modification-Enhanced Silencing Effect of Ad5-shPDGF-D Vector in Breast Cancer Cell Line MDA-MB-231.
Topics: Breast Neoplasms; Cell Line; Cell Line, Tumor; Chitosan; Female; Genetic Therapy; Genetic Vectors; Humans | 2023 |
Dual-pH responsive chitosan nanoparticles for improving in vivo drugs delivery and chemoresistance in breast cancer.
Topics: Breast Neoplasms; Chitosan; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Nanoparticles | 2022 |
Hormone receptor binding, selectivity and cytotoxicity of steroid D-homo lactone loaded chitosan nanoparticles for the treatment of breast and prostate cancer cells.
Topics: Breast Neoplasms; Chitosan; Hormones; Humans; Lactones; Male; Nanoparticles; Prostatic Neoplasms; Steroids | 2022 |
Stepwise responsive carboxymethyl chitosan-based nanoplatform for effective drug-resistant breast cancer suppression.
Topics: Breast Neoplasms; Chitosan; Doxorubicin; Drug Carriers; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Nanoparticles; RNA, Small Interfering | 2022 |
Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Chitosan; Doxorubicin; Female; Human Growth Hormone; Humans; MCF-7 Cells; Molecular Docking Simulation; Nanoparticles; Peptides | 2022 |
Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration.
Topics: Breast Neoplasms; Chitosan; Female; Humans; Hyaluronic Acid; Nanoparticles; Piperidones | 2022 |
Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice.
Topics: Animals; Ascites; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Chitosan; Cromolyn Sodium; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Genes, p16; Heterografts; Humans; Mice; Nanoparticles; RNA, Neoplasm | 2022 |
Engineered Magnetic Polymer Nanoparticles Can Ameliorate Breast Cancer Treatment Inducing Pyroptosis-Starvation along with Chemotherapy.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Emulsions; Female; Glucose Oxidase; Humans; Magnetic Phenomena; Nanoparticles; Paclitaxel; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyroptosis; Solvents | 2022 |
A new chitosan-based thermosensitive nanoplatform for combined photothermal and chemotherapy.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Delivery Systems; Female; Humans; Indocyanine Green; Mice; Nanoparticles; Tumor Microenvironment | 2022 |
Combination therapy with chitosan/siRNA nanoplexes targeting PDGF-D and PDGFR-β reveals anticancer effect in breast cancer.
Topics: Breast Neoplasms; Chitosan; Female; Humans; Nanostructures; Receptor, Platelet-Derived Growth Factor beta; RNA Interference; RNA, Small Interfering | 2023 |
An injectable and pH-responsive hyaluronic acid hydrogel as metformin carrier for prevention of breast cancer recurrence.
Topics: Breast Neoplasms; Chitosan; Drug Delivery Systems; Female; Humans; Hyaluronic Acid; Hydrogels; Hydrogen-Ion Concentration; Tumor Microenvironment | 2023 |
MCF-7 cells lack the expression of Caspase-3.
Topics: Apoptosis; Breast Neoplasms; Caspase 3; Caspase 9; Chitosan; Female; Humans; MCF-7 Cells | 2023 |
Paclitaxel-loaded liposome-incorporated chitosan (core)/poly(ε-caprolactone)/chitosan (shell) nanofibers for the treatment of breast cancer.
Topics: Breast Neoplasms; Chitosan; Female; Humans; Liposomes; Nanofibers; Paclitaxel; Polyesters | 2023 |
Preparation of chitosan nanoparticle containing recombinant CD44v antigen and evaluation of its immunization capacity against breast cancer in BALB/c mice.
Topics: Animals; Breast Neoplasms; Chitosan; Escherichia coli; Female; Humans; Immunization; Mice; Mice, Inbred BALB C; Nanoparticles; Recombinant Proteins | 2023 |
Development of Thiol-Maleimide hydrogels incorporating graphene-based nanomaterials for cancer chemo-photothermal therapy.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; Dihydroxyphenylalanine; Doxorubicin; Female; Graphite; Humans; Hyaluronic Acid; Hydrogels; Hyperthermia, Induced; Maleimides; Nanostructures; Phototherapy; Photothermal Therapy; Polymers; Sulfhydryl Compounds | 2023 |
Photosensitive Chitosan-Based Injectable Hydrogel Chemically Cross-Linked by Perylene Bisimide Dopamine with Robust Antioxidant and Cytotoxicity Enhancer Properties for In Vitro Photodynamic Therapy of Breast Cancer.
Topics: Antioxidants; Breast Neoplasms; Chitosan; Dihydroxyphenylalanine; Dopamine; Endothelial Cells; Female; Humans; Hydrogels; Perylene; Photochemotherapy; Reactive Oxygen Species | 2023 |
Conjugation of folic acid with poly (NVCL-co-PEGMA)-grafted chitosan as a new doxorubicin delivery system.
Topics: Breast Neoplasms; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Folic Acid; Humans; Hydrogen-Ion Concentration | 2023 |
Construction of carboxymethyl chitosan-based nanoparticles of hypoxia response for co-loading doxorubicin and tanshinone IIA.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Carriers; Female; Humans; Nanoparticles | 2023 |
In situ forming alginate/gelatin hybrid hydrogels containing doxorubicin loaded chitosan/AuNPs nanogels for the local therapy of breast cancer.
Topics: Breast Neoplasms; Chitosan; Doxorubicin; Drug Carriers; Female; Gelatin; Gold; Humans; Hydrogels; Hydrogen-Ion Concentration; Metal Nanoparticles; Nanogels | 2023 |
Chitosan-encapsulated nickel oxide, tin dioxide, and farnesol nanoparticles: Antimicrobial and anticancer properties in breast cancer cells.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Breast Neoplasms; Cell Line, Tumor; Chitosan; Ciliary Neurotrophic Factor; Farnesol; Female; Humans; Metal Nanoparticles; Spectroscopy, Fourier Transform Infrared | 2023 |
Preparation and characterization of pH-sensitive chitosan/starch/MoS
Topics: Breast Neoplasms; Chitosan; Curcumin; Drug Carriers; Drug Liberation; Female; Humans; Hydrogen-Ion Concentration; Molybdenum; Nanocomposites; Nanoparticles; Spectroscopy, Fourier Transform Infrared; Starch | 2023 |
Targeted Anticancer Drug Delivery Using Chitosan, Carbon Quantum Dots, and Aptamers to Deliver Ganoderic Acid and 5-Fluorouracil.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Fluorouracil; Humans; Male; Quantum Dots; Spectroscopy, Fourier Transform Infrared | 2023 |
Preparation, characterization, and in vitro cytotoxicity activity of allyl-isothiocyanate-embedded polymeric nanoparticles for potential breast cancer targeting.
Topics: Breast Neoplasms; Chitosan; Female; Humans; Isothiocyanates; Nanoparticles; Spectroscopy, Fourier Transform Infrared | 2023 |
The folate-linked chitosan-coated Kaempferol/HSA nano-transporters (FCKH-NTs) as the selective apoptotic inducer in human MCF-7 breast cancer cell line.
Topics: Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Chitosan; Female; Folic Acid; Humans; Kaempferols; MCF-7 Cells; Serum Albumin, Human | 2023 |
pH-sensitive biosystem based on laponite RD/chitosan/polyvinyl alcohol hydrogels for controlled delivery of curcumin to breast cancer cells.
Topics: Anti-Bacterial Agents; Antioxidants; Breast Neoplasms; Chitosan; Curcumin; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Female; Humans; Hydrogels; Hydrogen-Ion Concentration; Polyvinyl Alcohol; Spectroscopy, Fourier Transform Infrared | 2023 |
Caffeic acid-grafted chitosan/sodium alginate/nanoclay-based multifunctional 3D-printed hybrid scaffolds for local drug release therapy after breast cancer surgery.
Topics: Alginates; Animals; Breast Neoplasms; Chitosan; Drug Liberation; Female; Humans; Mastectomy; Neoplasm Recurrence, Local; Printing, Three-Dimensional; Tissue Scaffolds | 2024 |
Chitosan-mediated green synthesis and folic-acid modification of CuS quantum dots for photoacoustic imaging guided photothermal therapy of tumor.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Copper; Drug Screening Assays, Antitumor; Female; Folic Acid; Mice; Optical Imaging; Particle Size; Photoacoustic Techniques; Photochemotherapy; Quantum Dots; Surface Properties | 2019 |
Implementation of two different experimental designs for screening and optimization of process parameters for metformin-loaded carboxymethyl chitosan formulation.
Topics: Breast Neoplasms; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Compounding; Drug Liberation; Drug Screening Assays, Antitumor; Female; Humans; MCF-7 Cells; Metformin; Nanoparticles; Particle Size; Research Design; Toxicity Tests | 2019 |
Poliglusam Nanoparticles Activate T Cell Response in Breast Cancer Cell: an In Vivo and In Vitro Study.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Transformation, Neoplastic; Chitosan; Cytokines; Female; Humans; Lymphocyte Activation; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanoparticles; Spleen; T-Lymphocytes | 2019 |
Doxorubicin/cisplatin co-loaded hyaluronic acid/chitosan-based nanoparticles for in vitro synergistic combination chemotherapy of breast cancer.
Topics: Breast Neoplasms; Chitosan; Cisplatin; Doxorubicin; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Female; Humans; Hyaluronic Acid; MCF-7 Cells; Nanoparticles | 2019 |
Glycol Chitosan-Docosahexaenoic Acid Liposomes for Drug Delivery: Synergistic Effect of Doxorubicin-Rapamycin in Drug-Resistant Breast Cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chitosan; Docosahexaenoic Acids; Doxorubicin; Drug Delivery Systems; Drug Liberation; Drug Resistance, Neoplasm; Ecosystem; Female; Humans; Liposomes; Nanoparticles; Particle Size; Sirolimus | 2019 |
Development of conjugate-by-conjugate structured nanoparticles for oral delivery of docetaxel.
Topics: Administration, Oral; Antineoplastic Agents; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Chitosan; Docetaxel; Drug Carriers; Drug Delivery Systems; Female; Humans; Hydrogen-Ion Concentration; Hypromellose Derivatives; Intestinal Absorption; Nanoparticles; Particle Size; Vitamin E; X-Ray Diffraction | 2020 |
Incorporation of Zataria multiflora essential oil into chitosan biopolymer nanoparticles: A nanoemulsion based delivery system to improve the in-vitro efficacy, stability and anticancer activity of ZEO against breast cancer cells.
Topics: Apoptosis; Biopolymers; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; DNA Damage; Drug Delivery Systems; Emulsions; Female; Humans; Lamiaceae; Nanoparticles; Oils, Volatile | 2020 |
Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of Docetaxel and Thymoquinone by Chitosan grafted lipid nanocapsules: Formulation optimization, in vitro and in vivo studies.
Topics: Animals; Antineoplastic Agents; Benzoquinones; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Docetaxel; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Screening Assays, Antitumor; Female; Humans; Lipids; MCF-7 Cells; Nanocapsules; Neovascularization, Pathologic; Rats; Structure-Activity Relationship | 2020 |
Drug-loaded implantable surgical cavity-adaptive hydrogels for prevention of local tumor recurrence.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Deoxycytidine; Doxorubicin; Drug Implants; Drug Synergism; Female; Gemcitabine; Hyaluronic Acid; Hydrogels; Mice; Mice, Inbred BALB C; Neoplasm Recurrence, Local; Xenograft Model Antitumor Assays | 2020 |
Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression.
Topics: Breast Neoplasms; Cell Proliferation; Cell Survival; Chitosan; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Hyaluronic Acid; Interleukin-6; Nanoparticles; Neovascularization, Pathologic; RNA, Small Interfering; STAT3 Transcription Factor; Tumor Microenvironment | 2020 |
HER2 targeted biological macromolecule modified liposomes for improved efficacy of capecitabine in breast cancer.
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Cell Line, Tumor; Chitosan; Female; Humans; Liposomes; Peptides; Receptor, ErbB-2 | 2020 |
Stimuli-Responsive Polysaccharide Enveloped Liposome for Targeting and Penetrating Delivery of survivin-shRNA into Breast Tumor.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Gene Transfer Techniques; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; Liposomes; Mice; Mice, Inbred BALB C; NIH 3T3 Cells; Polysaccharides; RNA, Small Interfering; Survivin; Xenograft Model Antitumor Assays | 2020 |
A competent bidrug loaded water soluble chitosan derivative for the effective inhibition of breast cancer.
Topics: Breast Neoplasms; Chitosan; Doxorubicin; Drug Carriers; Drug Liberation; Fluorouracil; Humans; Inhibitory Concentration 50; MCF-7 Cells; Solubility; Water | 2020 |
Inhibition of chemotherapy-related breast tumor EMT by application of redox-sensitive siRNA delivery system CSO-ss-SA/siRNA along with doxorubicin treatment.
Topics: Amines; Antineoplastic Agents; Breast Neoplasms; Chitosan; Doxorubicin; Drug Delivery Systems; Epithelial-Mesenchymal Transition; Female; Humans; MCF-7 Cells; Neoplasm Metastasis; Oxidation-Reduction; rac1 GTP-Binding Protein; Reactive Oxygen Species; RNA, Small Interfering | 2020 |
Growth-Inhibitory Effect of Chitosan-Coated Liposomes Encapsulating Curcumin on MCF-7 Breast Cancer Cells.
Topics: Animals; Antineoplastic Agents; Biological Availability; Brassica rapa; Breast Neoplasms; Chitosan; Curcumin; Drug Carriers; Drug Compounding; Drug Delivery Systems; Female; Humans; Lecithins; Liposomes; MCF-7 Cells; Nanoparticles; Salmon; Tumor Cells, Cultured | 2020 |
RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Humans; Nanoparticles; Oligopeptides; Raloxifene Hydrochloride; Tumor Microenvironment | 2020 |
Coinhibition of S1PR1 and GP130 by siRNA-loaded alginate-conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cells.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chitosan; Cytokine Receptor gp130; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; Melanoma, Experimental; Mice; Nanoparticles; Proprotein Convertases; RNA, Small Interfering; Serine Endopeptidases; Sphingosine-1-Phosphate Receptors; STAT3 Transcription Factor; Tumor Microenvironment | 2020 |
NIR-dye based mucoadhesive nanosystem for photothermal therapy in breast cancer cells.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line; Cell Survival; Chitosan; Female; Fluorescent Dyes; Humans; Infrared Rays; Liposomes; Mice; Microscopy, Fluorescence; Mucins; Nanoparticles; Oxazines; Photosensitizing Agents; Photothermal Therapy | 2020 |
Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy.
Topics: Adenosine A2 Receptor Antagonists; Animals; Breast Neoplasms; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Chitosan; Dendritic Cells; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Lactic Acid; Mammary Neoplasms, Animal; Mice; Nanoparticles; Polyethylene Glycols; Receptor, Adenosine A2A; RNA, Small Interfering; T-Lymphocytes, Cytotoxic | 2020 |
Immobilization of Paclitaxel on Hydroxyapatite for Breast Cancer Investigations.
Topics: Breast Neoplasms; Cell Survival; Chitosan; Durapatite; Female; Humans; Nanoparticles; Paclitaxel | 2020 |
Chitosan-Raloxifene nanoparticle containing doxorubicin as a new double-effect targeting vehicle for breast cancer therapy.
Topics: Breast Neoplasms; Cell Proliferation; Cell Survival; Chitosan; Doxorubicin; Drug Compounding; Drug Delivery Systems; Drug Liberation; Female; Humans; MCF-7 Cells; Nanoparticles; Raloxifene Hydrochloride; Receptors, Estrogen | 2020 |
Cytotoxicity of Chitosan Ultrafine Nanoshuttles on the MCF-7 Cell Line as a Surrogate Model for Breast Cancer.
Topics: Breast Neoplasms; Chitosan; Drug Carriers; Female; Humans; MCF-7 Cells; Nanoparticles; Particle Size | 2021 |
Chitosan derived glycolipid nanoparticles for magnetic resonance imaging guided photodynamic therapy of cancer.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chitosan; Chlorophyllides; Disease Models, Animal; Drug Delivery Systems; Female; Gadolinium DTPA; Glycolipids; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Nanoparticles; Photochemotherapy; Porphyrins; Radiation-Sensitizing Agents; Stearic Acids; Tumor Burden | 2020 |
Antitumoral Drug: Loaded Hybrid Nanocapsules Based on Chitosan with Potential Effects in Breast Cancer Therapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Chitosan; Drug Liberation; Female; Fluorouracil; Humans; Kinetics; Magnetite Nanoparticles; MCF-7 Cells; Nanocapsules; Particle Size; Spectroscopy, Fourier Transform Infrared; Static Electricity; Temperature; Thermogravimetry | 2020 |
In Silico Molecular Interaction Studies of Chitosan Polymer with Aromatase Inhibitor: Leads to Letrozole Nanoparticles for the Treatment of Breast Cancer.
Topics: Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Letrozole; Molecular Docking Simulation; Molecular Structure; Nanoparticles; Polymers; Structure-Activity Relationship | 2021 |
Dual cancer targeting using estrogen functionalized chitosan nanoparticles loaded with doxorubicin-estrone conjugate: A quality by design approach.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Doxorubicin; Drug Compounding; Estrone; Female; Humans; MCF-7 Cells; Nanoparticles; Rats; Xenograft Model Antitumor Assays | 2020 |
3D printed intelligent scaffold prevents recurrence and distal metastasis of breast cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Chemotherapy, Adjuvant; Chitosan; Doxycycline; Drug Carriers; Drug Compounding; Female; Fluorouracil; Gelatin; Humans; Mammary Glands, Animal; Mastectomy; Mice; Neoplasm Metastasis; Neoplasm Recurrence, Local; Polylactic Acid-Polyglycolic Acid Copolymer; Printing, Three-Dimensional; Smart Materials; Surgical Wound; Tissue Scaffolds; Wound Healing; Xenograft Model Antitumor Assays | 2020 |
Biomolecule chitosan, curcumin and ZnO-based antibacterial nanomaterial, via a one-pot process.
Topics: Anti-Bacterial Agents; Breast Neoplasms; Chitosan; Curcumin; Escherichia coli; Female; Humans; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nanostructures; Zinc Oxide | 2020 |
Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chick Embryo; Chitosan; Colonic Neoplasms; Drug Delivery Systems; Drug Liberation; Female; Humans; Interleukin-6; Lactic Acid; Magnetic Resonance Spectroscopy; Mice, Inbred BALB C; Nanoparticles; Neovascularization, Pathologic; Oligopeptides; Polyethylene Glycols; RNA, Small Interfering; Spectroscopy, Fourier Transform Infrared; Xenograft Model Antitumor Assays | 2020 |
Guiding Appropriate Timing of Laser Irradiation by Polymeric Micelles for Maximizing Chemo-Photodynamic Therapy.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chitosan; Chlorophyllides; Doxorubicin; Drug Delivery Systems; Drug Liberation; Female; Humans; Lasers; Mice, Inbred BALB C; Micelles; Nanostructures; Photochemotherapy; Photosensitizing Agents; Polymers; Porphyrins; Precision Medicine; Rabbits; Spectrometry, Fluorescence | 2020 |
Chitosan/carbon quantum dot/aptamer complex as a potential anticancer drug delivery system towards the release of 5-fluorouracil.
Topics: Antineoplastic Agents; Aptamers, Nucleotide; Breast Neoplasms; Carbon; Cell Proliferation; Cell Survival; Chitosan; Drug Delivery Systems; Drug Liberation; Female; Fluorouracil; Humans; MCF-7 Cells; Nanoparticles; Quantum Dots | 2020 |
A three dimensional in vivo model of breast cancer using a thermosensitive chitosan-based hydrogel and 4 T1 cell line in Balb/c.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chitosan; Female; Glycerophosphates; Humans; Hydrogels; Mammary Neoplasms, Animal; Mice, Inbred BALB C; Neoplastic Stem Cells; Temperature; Tissue Scaffolds | 2021 |
Chlorambucil-Chitosan Nano-Conjugate: An Efficient Agent Against Breast Cancer Targeted Therapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Chitosan; Chlorambucil; Humans; MCF-7 Cells; Nanoconjugates; Prospective Studies | 2021 |
A targeted and redox/pH-responsive chitosan oligosaccharide derivatives based nanohybrids for overcoming multidrug resistance of breast cancer cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Chitosan; Drug Carriers; Drug Liberation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Folic Acid; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Nanoparticles; Oxidation-Reduction; Paclitaxel; Polyethyleneimine; RNA, Small Interfering | 2021 |
Biodegradable nanocarriers based on chitosan-modified mesoporous silica nanoparticles for delivery of methotrexate for application in breast cancer treatment.
Topics: Breast Neoplasms; Chitosan; Drug Delivery Systems; Humans; Methotrexate; Nanoparticles; Porosity; Silicon Dioxide | 2021 |
Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice.
Topics: Animals; Apoptosis; B7-H1 Antigen; Breast Neoplasms; Cell Movement; Cell Proliferation; Chitosan; Disease Progression; Female; Gene Products, tat; Humans; Hyaluronic Acid; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; RNA, Small Interfering; STAT3 Transcription Factor; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
[Reversal effect of peptide-modified chitosan tetramethylpyrazine nanoparticles on multidrug resistance in tumor cells].
Topics: Breast Neoplasms; Chitosan; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Nanoparticles; Peptides; Pyrazines | 2020 |
A 3D hydrogel based on chitosan and carbon dots for sensitive fluorescence detection of microRNA-21 in breast cancer cells.
Topics: Breast Neoplasms; Carbon; Chitosan; Humans; Hydrogels; MicroRNAs; Quantum Dots; Spectroscopy, Fourier Transform Infrared | 2021 |
Modification of magnetic molybdenum disulfide by chitosan/carboxymethylcellulose with enhanced dispersibility for targeted photothermal-/chemotherapy of cancer.
Topics: Adsorption; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Carboxymethylcellulose Sodium; Cell Survival; Chitosan; Disulfides; Doxorubicin; Drug Screening Assays, Antitumor; Female; Humans; Magnetic Phenomena; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Molybdenum; Nanocomposites; Particle Size; Phototherapy; Surface Properties; Tumor Cells, Cultured | 2021 |
Cytotoxicity Effects of Curcumin Loaded on Chitosan Alginate Nanospheres on the KMBC-10 Spheroids Cell Line.
Topics: Alginates; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Chitosan; Curcumin; Female; Fluorescence; Folic Acid; Gene Expression Regulation; Humans; Inhibitory Concentration 50; Male; Nanospheres; Particle Size; Solubility; Spectroscopy, Fourier Transform Infrared; Spheroids, Cellular | 2021 |
Fabrication of carboxymethyl chitosan/poly(ε-caprolactone)/doxorubicin/nickel ferrite core-shell fibers for controlled release of doxorubicin against breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Delivery Systems; Drug Liberation; Drug Screening Assays, Antitumor; Female; Ferric Compounds; Humans; Hydrogen-Ion Concentration; Magnetic Fields; MCF-7 Cells; Metal Nanoparticles; Nanofibers; Nickel; Polyesters | 2021 |
Microfluidics-assisted conjugation of chitosan-coated polymeric nanoparticles with antibodies: Significance in drug release, uptake, and cytotoxicity in breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Liberation; Female; Humans; Microfluidics; Nanoparticles | 2021 |
Blockade of HIF-1α and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Colonic Neoplasms; Female; Humans; Hyaluronic Acid; Hypoxia-Inducible Factor 1, alpha Subunit; Magnetic Iron Oxide Nanoparticles; Mice; Mice, Inbred BALB C; RNA, Small Interfering; STAT3 Transcription Factor | 2021 |
Simple and fast isolation of circulating exosomes with a chitosan modified shuttle flow microchip for breast cancer diagnosis.
Topics: Biomarkers, Tumor; Breast Neoplasms; Chitosan; Exosomes; Female; Humans; MicroRNAs | 2021 |
Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Chitosan; Copper; Doxorubicin; Drug Liberation; Humans; Mice; Nanoparticles; Phototherapy; Precision Medicine; Silicon Dioxide; Sulfides; Tumor Microenvironment | 2021 |
Cell detachment ratio on pH-responsive chitosan: A useful biometric for prognostic judgment and drug efficacy assessment in oncology.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Line, Tumor; Chitosan; Female; Humans; Hydrogen-Ion Concentration; Lung Neoplasms; Medical Oncology; Mice; Mice, Nude; Particle Size; Prognosis; Treatment Outcome; Xenograft Model Antitumor Assays | 2021 |
Fucoidan/chitosan nanoparticles functionalized with anti-ErbB-2 target breast cancer cells and impair tumor growth in vivo.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; Endothelial Cells; Female; Humans; Nanoparticles; Polysaccharides | 2021 |
Chitosan Membranes Filled with Cyclosporine A as Possible Devices for Local Administration of Drugs in the Treatment of Breast Cancer.
Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Cyclosporine; Drug Carriers; Humans; Membranes; Swine | 2021 |
Evaluation of the effect of 3D porous Chitosan-alginate scaffold stiffness on breast cancer proliferation and migration.
Topics: Alginates; Breast Neoplasms; Cell Count; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Chitosan; Female; Humans; Polyelectrolytes; Porosity; Spectroscopy, Fourier Transform Infrared; Tissue Scaffolds | 2021 |
A label-free electrochemical aptasensor for breast cancer cell detection based on a reduced graphene oxide-chitosan-gold nanoparticle composite.
Topics: Aptamers, Nucleotide; Biosensing Techniques; Breast Neoplasms; Chitosan; Electrochemistry; Gold; Graphite; Humans; Limit of Detection; MCF-7 Cells; Metal Nanoparticles; Oxidation-Reduction | 2021 |
Extraction of chlorophyll and carotenoids loaded into chitosan as potential targeted therapy and bio imaging agents for breast carcinoma.
Topics: Apoptosis; Breast Neoplasms; Carotenoids; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Chlorophyll; Female; Flow Cytometry; Humans; Hydrogels; Necrosis | 2021 |
Synthesis and characterization of chitosan/polyvinylpyrrolidone coated nanoporous γ-Alumina as a pH-sensitive carrier for controlled release of quercetin.
Topics: Aluminum Oxide; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Liberation; Female; Humans; Hydrogen-Ion Concentration; Kinetics; MCF-7 Cells; Nanopores; Povidone; Quercetin | 2021 |
ATP/Hyals dually responsive core-shell hyaluronan/chitosan-based drug nanocarrier for potential application in breast cancer therapy.
Topics: Adenosine Triphosphate; Breast Neoplasms; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Carriers; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Hydrogen-Ion Concentration; MCF-7 Cells; Nanoparticles; Quaternary Ammonium Compounds | 2021 |
Optimally designed theranostic system based folic acids and chitosan as a promising mucoadhesive delivery system for encapsulating curcumin LbL nano-template against invasiveness of breast cancer.
Topics: Adhesiveness; Adsorption; Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Death; Cell Shape; Chitosan; Curcumin; Drug Compounding; Drug Delivery Systems; Drug Liberation; Female; Folic Acid; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Nanoparticles; Necrosis; Neoplasm Invasiveness; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Static Electricity; Stereoisomerism; Theranostic Nanomedicine | 2021 |
A chitosan/mesoporous silica nanoparticle-based anticancer drug delivery system with a "tumor-triggered targeting" property.
Topics: Adamantane; Animals; Antibiotics, Antineoplastic; Benzimidazoles; beta-Cyclodextrins; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Compounding; Female; Hydrogen-Ion Concentration; Mice; Mice, Inbred BALB C; Nanoparticles; Oligopeptides; Polyethylene Glycols; Porosity; Silicates; Tumor Burden | 2021 |
Curcumin Loaded Chitosan-Protamine Nanoparticles Revealed Antitumor Activity Via Suppression of NF-κB, Proinflammatory Cytokines and Bcl-2 Gene Expression in the Breast Cancer Cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Chitosan; Curcumin; Cytokines; Drug Carriers; Female; Gene Expression; Humans; Nanoparticles; NF-kappa B; Protamines; Spectroscopy, Fourier Transform Infrared | 2021 |
Targeted doxorubicin delivery and release within breast cancer environment using PEGylated chitosan nanoparticles labeled with monoclonal antibodies.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Breast Neoplasms; Cell Line; Cell Proliferation; Cell Survival; Chitosan; Delayed-Action Preparations; Dose-Response Relationship, Drug; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Humans; Hydrogen-Ion Concentration; Mammaglobin A; MCF-7 Cells; Mice; Nanoparticles; Polyethylene Glycols; Receptor, ErbB-2; Tumor Microenvironment | 2021 |
Novel quercetin encapsulated chitosan functionalized copper oxide nanoparticles as anti-breast cancer agent via regulating p53 in rat model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Breast Neoplasms; Caco-2 Cells; Cell Cycle; Cell Proliferation; Cell Survival; Chitosan; Copper; Drug Compounding; Female; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; MCF-7 Cells; Metal Nanoparticles; Proliferating Cell Nuclear Antigen; Quercetin; Rats; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2021 |
Hydroxyethyl chitosan hydrogels for enhancing breast cancer cell tumorigenesis.
Topics: Breast Neoplasms; Cell Movement; Cell Proliferation; Chitosan; Extracellular Matrix; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronic Acid; Hydrogels; Matrix Metalloproteinase 2; MCF-7 Cells; Porosity; Schiff Bases; Spheroids, Cellular; Transforming Growth Factor beta; Tumor Cells, Cultured; Up-Regulation; Vascular Endothelial Growth Factor A | 2021 |
Enhanced radiotherapy efficacy of breast cancer multi cellular tumor spheroids through in-situ fabricated chitosan-zinc oxide bio-nanocomposites as radio-sensitizing agents.
Topics: Breast Neoplasms; Chitosan; Female; Humans; Nanocomposites; Nanoparticles; Tumor Microenvironment; Zinc Oxide | 2021 |
Chitosan nanoparticles containing limonene and limonene-rich essential oils: potential phytotherapy agents for the treatment of melanoma and breast cancers.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Chitosan; Citrus; Drug Delivery Systems; Female; Humans; Limonene; Melanoma; Nanoparticles; Phytotherapy | 2021 |
Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo.
Topics: 5'-Nucleotidase; Animals; Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chitosan; Colorectal Neoplasms; Doxorubicin; Drug Compounding; Female; GPI-Linked Proteins; Hyaluronic Acid; Lactates; Mice; Mice, Inbred BALB C; Nanoparticles; Nanotechnology; Neoplasm Invasiveness; Neovascularization, Pathologic; RNA, Small Interfering; RNAi Therapeutics; tat Gene Products, Human Immunodeficiency Virus | 2021 |
Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
Topics: Animals; Breast Neoplasms; Cell Line; Cell Line, Tumor; Chitosan; Deoxycytidine; Female; Folic Acid; Gemcitabine; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Nanoparticles; Particle Size; Rats; Silver | 2021 |
Mitotropic triphenylphosphonium doxorubicin-loaded core-shell nanoparticles for cellular and mitochondrial sequential targeting of breast cancer.
Topics: Animals; Breast Neoplasms; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Humans; Mice; Nanoparticles | 2021 |
Anticancer Effect of Alginate-chitosan Hydrogel Loaded with Curcumin and Chrysin on Lung and Breast Cancer Cell Lines.
Topics: Alginates; Antineoplastic Agents; Breast Neoplasms; Cell Line; Chitosan; Curcumin; Drug Carriers; Female; Flavonoids; Humans; Hydrogels; Lung | 2022 |
Application of silver nanotriangles as a novel contrast agent in tumor computed tomography imaging.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chitosan; Contrast Media; Dynamic Light Scattering; Female; Humans; Metal Nanoparticles; Mice; Microscopy, Electron, Transmission; Neoplasm Transplantation; Particle Size; Silver; X-Ray Microtomography | 2021 |
Artemisinin loaded chitosan magnetic nanoparticles for the efficient targeting to the breast cancer.
Topics: Animals; Antineoplastic Agents; Artemisinins; Breast Neoplasms; Cell Line, Tumor; Chitosan; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Liberation; Female; Humans; Magnetite Nanoparticles; Mice; Particle Size; Spectroscopy, Fourier Transform Infrared; Xenograft Model Antitumor Assays | 2017 |
Chitosan nanoparticle-delivered siRNA reduces
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Survival; Chitosan; Cisplatin; Female; Gene Transfer Techniques; Humans; MCF-7 Cells; Nanoparticles; Receptors, CXCR4; RNA, Small Interfering; RNAi Therapeutics | 2017 |
Fabrication and study of curcumin loaded nanoparticles based on folate-chitosan for breast cancer therapy application.
Topics: Breast Neoplasms; Chitosan; Curcumin; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Hydrogen-Ion Concentration; Nanoparticles; Particle Size | 2017 |
siRNA-loaded poly(histidine-arginine)
Topics: Animals; Arginine; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell-Penetrating Peptides; Chitosan; Endosomes; Female; Histidine; Humans; Mice, Inbred BALB C; Nanoparticles; RNA, Small Interfering; Transfection; Xenograft Model Antitumor Assays | 2017 |
Effect of silibinin-loaded nano-niosomal coated with trimethyl chitosan on miRNAs expression in 2D and 3D models of T47D breast cancer cell line.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; Coated Materials, Biocompatible; Drug Carriers; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Nanoparticles; RNA, Neoplasm; Silybin; Silymarin | 2018 |
Chitosan-Dextran sulfate coated doxorubicin loaded PLGA-PVA-nanoparticles caused apoptosis in doxorubicin resistance breast cancer cells through induction of DNA damage.
Topics: Apoptosis; Breast Neoplasms; Cell Movement; Chitosan; Dextran Sulfate; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Models, Biological; Nanoparticles; Oligopeptides; Polylactic Acid-Polyglycolic Acid Copolymer | 2017 |
Chitosan stabilized camptothecin nanoemulsions: Development, evaluation and biodistribution in preclinical breast cancer animal mode.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Cell Line, Tumor; Cell Survival; Chitosan; Disease Models, Animal; Drug Carriers; Drug Evaluation, Preclinical; Drug Liberation; Drug Stability; Emulsions; Female; Humans; MCF-7 Cells; Mice; Nanoparticles; Tissue Distribution; Xenograft Model Antitumor Assays | 2017 |
Polysaccharide-based nanoparticles for co-loading mitoxantrone and verapamil to overcome multidrug resistance in breast tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Mitoxantrone; Nanoparticles; Polyelectrolytes; Verapamil | 2017 |
Glycol chitosan assisted in situ reduction of gold on polymeric template for anti-cancer theranostics.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Chitosan; Female; Gold; Humans; Hyperthermia, Induced; Lactic Acid; MCF-7 Cells; Mice; Nanoshells; Oxidation-Reduction; Photochemotherapy; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Theranostic Nanomedicine | 2018 |
Chitosan/poly (lactic acid)-coated piceatannol nanoparticles exert an in vitro apoptosis activity on liver, lung and breast cancer cell lines.
Topics: Apoptosis; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Chitosan; DNA Fragmentation; Drug Carriers; Drug Liberation; Humans; Liver; Lung Neoplasms; MCF-7 Cells; Nanoparticles; Nitric Oxide; Picrates; Polyesters; Stilbenes; Superoxide Dismutase | 2018 |
A Microfluidic Chip Integrated with Hyaluronic Acid-Functionalized Electrospun Chitosan Nanofibers for Specific Capture and Nondestructive Release of CD44-Overexpressing Circulating Tumor Cells.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chitosan; Female; Glutathione; Humans; Hyaluronan Receptors; Hyaluronic Acid; Lung Neoplasms; Microfluidic Analytical Techniques; Nanofibers; Neoplastic Cells, Circulating | 2018 |
Curcumin diethyl disuccinate encapsulated in chitosan/alginate nanoparticles for improvement of its
Topics: Alginates; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Chitosan; Curcumin; Drug Compounding; Drug Stability; Emulsions; Excipients; Female; Humans; Nanoparticles; Poloxamer; Prodrugs; Succinates | 2016 |
Chitosan Stabilized Gold-Folate-Poly(lactide-co-glycolide) Nanoplexes Facilitate Efficient Gene Delivery in Hepatic and Breast Cancer Cells.
Topics: Breast Neoplasms; Chitosan; Female; Folic Acid; Genetic Therapy; Gold; Humans; Lactic Acid; Nanoparticles; Particle Size; Polyglactin 910; Polyglycolic Acid | 2018 |
'In Vitro', 'In Vivo' and 'In Silico' Investigation of the Anticancer Effectiveness of Oxygen-Loaded Chitosan-Shelled Nanodroplets as Potential Drug Vector.
Topics: Animals; Antineoplastic Agents; Breast Carcinoma In Situ; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chitosan; Computer Simulation; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Fluorocarbons; Humans; Mice; Mice, Inbred BALB C; Models, Biological; Nanoparticles; Oxygen | 2018 |
Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancer.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Cholesterol; Delayed-Action Preparations; Drug Liberation; Female; Gold; Hexoses; Hydrogen-Ion Concentration; Liposomes; Metal Nanoparticles; Mice; Tamoxifen; Tissue Distribution | 2018 |
N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Biological Availability; Breast Neoplasms; Caco-2 Cells; Cell Survival; Chitosan; Deoxycytidine; Female; Gemcitabine; HT29 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Peptide Fragments; Rats; Rats, Sprague-Dawley; Swine; Treatment Outcome | 2018 |
Development of novel biotinylated chitosan-decorated docetaxel-loaded nanocochleates for breast cancer targeting.
Topics: Animals; Antineoplastic Agents; Biotin; Breast Neoplasms; Chelating Agents; Chitosan; Delayed-Action Preparations; Docetaxel; Drug Carriers; Drug Design; Humans; MCF-7 Cells; Molecular Targeted Therapy; Nanostructures; Phosphatidylglycerols; Rats; Tissue Distribution | 2018 |
Application of a simple desolvation method to increase the formation yield, physical stability and hydrophobic drug encapsulation capacity of chitosan-based nanoparticles.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Buffers; Cell Survival; Chitosan; Culture Media; Drug Carriers; Drug Compounding; Drug Stability; Female; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; MCF-7 Cells; Molecular Dynamics Simulation; Nanoparticles; Nanotechnology; Paclitaxel; Technology, Pharmaceutical | 2018 |
Formulation of nanoparticles ribosome inactivating proteins from Mirabilis jalapa L. (RIP MJ) conjugated AntiEpCAM antibody using low chain chitosan-pectin and cytotoxic activity against breast cancer cell line.
Topics: Antibodies; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Epithelial Cell Adhesion Molecule; Female; Humans; Microscopy, Electron, Transmission; Mirabilis; Nanoparticles; Pectins; Ribosome Inactivating Proteins | 2018 |
Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer.
Topics: Animals; Apoptosis; Biocompatible Materials; Breast Neoplasms; Chitosan; Drug Delivery Systems; Estrone; Female; Humans; Hydrogen-Ion Concentration; Ligands; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Transplantation; Particle Size; Polysaccharides; Tissue Distribution | 2018 |
Chitosan-alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer.
Topics: Alginates; Animals; Antineoplastic Agents; Breast Neoplasms; Capsules; Cell Line, Tumor; Cell Proliferation; Chitosan; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Gels; Glucuronic Acid; Hexuronic Acids; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Serum Albumin, Bovine; Structure-Activity Relationship | 2018 |
Tamoxifen citrate loaded chitosan-gellan nanocapsules for breast cancer therapy: development, characterisation and in-vitro cell viability study.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Survival; Chitosan; Drug Liberation; Female; Humans; MCF-7 Cells; Nanocapsules; Polysaccharides, Bacterial; Tamoxifen | 2018 |
Seleno-short-chain chitosan induces apoptosis in human breast cancer cells through mitochondrial apoptosis pathway in vitro.
Topics: Apoptosis; Breast Neoplasms; Cell Cycle; Cell Shape; Chitosan; Female; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Mitochondria; Organoselenium Compounds; Reactive Oxygen Species | 2018 |
Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells
Topics: Animals; Aptamers, Nucleotide; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chitosan; CHO Cells; Cricetinae; Cricetulus; Docetaxel; Drug Liberation; Gene Expression Regulation, Neoplastic; Gene Silencing; Heparin; Humans; Mucin-1; Nanoparticles; Neoplasm Metastasis; Particle Size; Receptor, IGF Type 1; Receptors, Somatomedin; RNA, Small Interfering; Serum; Static Electricity | 2019 |
In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles.
Topics: A549 Cells; Animals; Antineoplastic Agents; Breast Neoplasms; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Liberation; Female; Humans; Kinetics; Lung Neoplasms; Male; Mice, Inbred C57BL; Nanomedicine; Nanoparticles; Quercetin; Solubility; Superoxide Dismutase; Technology, Pharmaceutical; Tissue Distribution; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2018 |
Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells.
Topics: Animals; Antioxidants; Breast Neoplasms; Cell Proliferation; Chitosan; Diffusion; Drug Compounding; Drug Delivery Systems; Drug Liberation; Female; Hemolysis; Humans; Light; MCF-7 Cells; Nanoparticles; Particle Size; Quercetin; Scattering, Radiation; Swine | 2018 |
Gemcitabine delivered by fucoidan/chitosan nanoparticles presents increased toxicity over human breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Survival; Chitosan; Deoxycytidine; Drug Delivery Systems; Endothelial Cells; Gemcitabine; Humans; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Polymers; Polysaccharides | 2018 |
Internalization capabilities of gold-198 nanoparticles: Comparative evaluation of effects of chitosan agent on cellular uptake into MCF-7.
Topics: Biological Transport, Active; Breast Neoplasms; Chitosan; Coated Materials, Biocompatible; Drug Delivery Systems; Endocytosis; Exocytosis; Female; Gold Radioisotopes; Humans; MCF-7 Cells; Metal Nanoparticles; Nanotechnology; Particle Size; Radiopharmaceuticals; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2018 |
Trastuzumab decorated TPGS-g-chitosan nanoparticles for targeted breast cancer therapy.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biological Availability; Breast Neoplasms; Cell Line, Tumor; Chitosan; Docetaxel; Drug Carriers; Female; Glycoconjugates; Humans; Kidney; Liver; Lung; Molecular Targeted Therapy; Nanoparticles; Rats; Receptor, ErbB-2; Trastuzumab; Tumor Burden; Vitamin E; Xenograft Model Antitumor Assays | 2019 |
Sequentially self-assembled polysaccharide-based nanocomplexes for combined chemotherapy and photodynamic therapy of breast cancer.
Topics: Aminolevulinic Acid; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Chitosan; Doxorubicin; Drug Carriers; Drug Liberation; Fluorescence; Humans; Hyaluronic Acid; Light; MCF-7 Cells; Mice; Nanoparticles; Particle Size; Photosensitizing Agents; Protoporphyrins | 2019 |
Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Topics: Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Cell Proliferation; Cell Survival; Chitosan; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Drug Liberation; Drug Screening Assays, Antitumor; Female; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Metal-Organic Frameworks; Nanostructures; Particle Size; Structure-Activity Relationship; Surface Properties | 2018 |
Effect of chitosan based glycolipid-like nanocarrier in prevention of developing acquired drug resistance in tri-cycle treatment of breast cancer.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Glycolipids; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Xenograft Model Antitumor Assays | 2019 |
Anti-proliferative effect of chitosan nanoparticles (extracted from crayfish Procambarus clarkii, Crustacea: Cambaridae) against MDA-MB-231 and SK-BR-3 human breast cancer cell lines.
Topics: Acetylation; Animals; Astacoidea; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Female; Humans; Nanoparticles; Particle Size; Spectroscopy, Fourier Transform Infrared; Static Electricity | 2019 |
EGFR detection in extracellular vesicles of breast cancer patients through immunosensor based on silica-chitosan nanoplatform.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; ErbB Receptors; Extracellular Vesicles; Humans; Immunoassay; Lab-On-A-Chip Devices; Limit of Detection; Nanostructures; Silicon Dioxide | 2019 |
Dual thermo-and pH-sensitive injectable hydrogels of chitosan/(poly(N-isopropylacrylamide-co-itaconic acid)) for doxorubicin delivery in breast cancer.
Topics: Acrylic Resins; Breast Neoplasms; Cell Proliferation; Chitosan; Doxorubicin; Drug Carriers; Drug Liberation; Humans; Hydrogels; Hydrogen-Ion Concentration; Injections; MCF-7 Cells; Succinates; Temperature | 2019 |
Phototherapy using immunologically modified carbon nanotubes to potentiate checkpoint blockade for metastatic breast cancer.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Chitosan; Female; Humans; Immunity; Immunotherapy; Mice, Inbred BALB C; Nanotubes, Carbon; Neoplasm Metastasis; Phototherapy | 2019 |
Chitosan nanogels as nanocarriers of polyoxometalates for breast cancer therapies.
Topics: Antineoplastic Agents; Breast Neoplasms; Chitosan; Drug Carriers; Female; Humans; Hydrogen-Ion Concentration; Nanogels; Particle Size; Polyethylene Glycols; Polyethyleneimine; Surface Properties; Tungsten Compounds | 2019 |
Simultaneous controlled release of 5-FU, DOX and PTX from chitosan/PLA/5-FU/g-C3N4-DOX/g-C3N4-PTX triaxial nanofibers for breast cancer treatment in vitro.
Topics: Breast Neoplasms; Cell Adhesion; Cell Survival; Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Liberation; Female; Fluorouracil; Graphite; Humans; Kinetics; MCF-7 Cells; Nanofibers; Nitriles; Paclitaxel; Polyesters; X-Ray Diffraction | 2019 |
Dual-responsive nanoparticles based on chitosan for enhanced breast cancer therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Liberation; Ethylene Glycols; Female; Human Umbilical Vein Endothelial Cells; Humans; Hyaluronic Acid; Methacrylates; Mice; Nanoparticles; Paclitaxel; Rats, Sprague-Dawley; Xenograft Model Antitumor Assays | 2019 |
Cytotoxic effects and apoptosis induction of cisplatin-loaded iron oxide nanoparticles modified with chitosan in human breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Death; Cell Line, Tumor; Chitosan; Cisplatin; Drug Delivery Systems; Female; Ferric Compounds; Humans; Metal Nanoparticles; Nanoparticles | 2019 |
Tailoring the Chemical Modification of Chitosan Hydrogels to Fine-Tune the Release of a Synergistic Combination of Chemotherapeutics.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chitosan; Deoxycytidine; Doxorubicin; Drug Carriers; Drug Liberation; Drug Synergism; Female; Gemcitabine; Humans; Hydrogels; Polymers | 2019 |
Photoacoustic imaging of cancer cells with glycol-chitosan-coated gold nanoparticles as contrast agents.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; Contrast Media; Endocytosis; Female; Gold; Humans; Metal Nanoparticles; Phantoms, Imaging; Photoacoustic Techniques; Signal Transduction; Spectrophotometry, Ultraviolet; Surface Properties; Time Factors | 2019 |
Modulation of the dual-faced effects of miR-141 with chitosan/miR-141 nanoplexes in breast cancer cells.
Topics: Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Movement; Chitosan; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Nanoparticles; RNA Interference; Vascular Endothelial Growth Factor A | 2019 |
Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells.
Topics: Anticarcinogenic Agents; Apoptosis; Breast Neoplasms; Catechin; Cell Proliferation; Cell Survival; Chitosan; Female; Humans; Liposomes; MCF-7 Cells; Nanoconjugates | 2013 |
Semi-IPN chitosan/polyvinylpyrrolidone microspheres and films: sustained release and property optimisation.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Breast Neoplasms; Cell Line; Chitosan; Delayed-Action Preparations; Female; Fluorouracil; Humans; Microspheres; Povidone | 2013 |
Effects of chemically modified nanostructured PLGA on functioning of lung and breast cancer cells.
Topics: Alginates; Analysis of Variance; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Female; Glucuronic Acid; Hexuronic Acids; Humans; Lactic Acid; Lung Neoplasms; Nanostructures; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties | 2013 |
pH-responsive drug delivery of chitosan nanoparticles as Tamoxifen carriers for effective anti-tumor activity in breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Chitosan; Drug Carriers; Drug Delivery Systems; Endocytosis; Female; Humans; Hydrogen-Ion Concentration; Light; MCF-7 Cells; Models, Biological; Nanoparticles; Particle Size; Scattering, Radiation; Static Electricity; Tamoxifen; Time Factors | 2013 |
N-lauroyl chitosan surface-modified PLGA nanoparticles as carrier for adriamycin to overcome cancer drug resistance.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Carriers; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2014 |
Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast; Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Female; Humans; Mice; Mice, Nude; Nanoparticles; Paclitaxel | 2013 |
Cell chip with a thiolated chitosan self-assembled monolayer to detect the effects of anticancer drugs on breast normal and cancer cells.
Topics: Antineoplastic Agents; Breast; Breast Neoplasms; Cell Line; Cell Tracking; Cells, Immobilized; Chitosan; Coated Materials, Biocompatible; Drug Screening Assays, Antitumor; Electrochemical Techniques; Female; Gold; Humans; Materials Testing; MCF-7 Cells | 2013 |
Synthesis and characterization of micelles as carriers of non-steroidal anti-inflammatory drugs (NSAID) for application in breast cancer therapy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Female; Humans; Ibuprofen; Magnetic Resonance Spectroscopy; Micelles | 2014 |
Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Proliferation; Chitosan; Doxorubicin; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flow Cytometry; Humans; Liver Neoplasms; Mice; Nanoparticles; Polyethylene Glycols; Polymers; Tissue Distribution; Tumor Cells, Cultured; Vitamin E; Xenograft Model Antitumor Assays | 2014 |
Investigation of the therapeutic efficacy of codelivery of psiRNA-vascular endothelial growth factor and pIL-4 into chitosan nanoparticles in the breast tumor model.
Topics: Animals; Breast; Breast Neoplasms; Chitosan; Female; Gene Silencing; Gene Transfer Techniques; Humans; Injections, Intraperitoneal; Interleukin-4; MCF-7 Cells; Nanoparticles; Neovascularization, Pathologic; Plasmids; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Solubility; Transfection; Tumor Burden; Vascular Endothelial Growth Factor A | 2014 |
Oxaliplatin-chitosan nanoparticles induced intrinsic apoptotic signaling pathway: a "smart" drug delivery system to breast cancer cell therapy.
Topics: Antineoplastic Agents; Apoptosis; Biological Transport; Breast Neoplasms; Cell- and Tissue-Based Therapy; Chitosan; Drug Carriers; Humans; MCF-7 Cells; Nanoparticles; Organoplatinum Compounds; Oxaliplatin; Signal Transduction | 2014 |
Enrichment of breast cancer stem-like cells by growth on electrospun polycaprolactone-chitosan nanofiber scaffolds.
Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Chitosan; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Nanofibers; Nanomedicine; Neoplastic Stem Cells; Polyesters; Taxoids; Tissue Scaffolds; Tumor Stem Cell Assay | 2014 |
Synergistic effects of glycated chitosan with high-intensity focused ultrasound on suppression of metastases in a syngeneic breast tumor model.
Topics: Animals; Biomarkers, Tumor; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Movement; Chitosan; Diagnostic Imaging; Disease Models, Animal; Epithelial-Mesenchymal Transition; Female; Genes, Reporter; High-Intensity Focused Ultrasound Ablation; Humans; Macrophages; Mice, Inbred BALB C; Neoplasm Invasiveness; Neoplasm Metastasis; Transfection | 2014 |
Chitosan-based thermoreversible hydrogel as an in vitro tumor microenvironment for testing breast cancer therapies.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Cytokines; Drug Resistance, Neoplasm; Female; Hydrogel, Polyethylene Glycol Dimethacrylate; Intercellular Signaling Peptides and Proteins; Mice; Neovascularization, Pathologic; Polyethylene Glycols; Tumor Microenvironment | 2014 |
Formulation and evaluation of chitosan-based long-acting injectable hydrogel for PEGylated melphalan conjugate.
Topics: Antineoplastic Agents, Alkylating; Breast Neoplasms; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Glycerophosphates; Hemolysis; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogels; Injections; Melphalan; Rheology; Solubility; Temperature | 2014 |
Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Bufanolides; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Permeability; Reactive Oxygen Species; Receptors, Growth Factor | 2014 |
In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Female; Folic Acid; Humans; Mice; Micelles; Paclitaxel; Polyethylene Glycols | 2016 |
A recyclable chitosan-based QCM biosensor for sensitive and selective detection of breast cancer cells in real time.
Topics: Biosensing Techniques; Breast Neoplasms; Chitosan; Endothelial Cells; Epithelial Cells; Female; Humans; MCF-7 Cells; Quartz Crystal Microbalance Techniques; Reproducibility of Results; Sensitivity and Specificity; Spectroscopy, Fourier Transform Infrared | 2014 |
Engineering a biomimetic three-dimensional nanostructured bone model for breast cancer bone metastasis study.
Topics: Biomimetic Materials; Bone Neoplasms; Breast Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chitosan; Crystallization; Durapatite; Female; Humans; Imaging, Three-Dimensional; Mesenchymal Stem Cells; Microscopy, Electron, Transmission; Models, Biological; Nanostructures; Neoplasm Invasiveness; Osteogenesis; Tissue Engineering; Tissue Scaffolds | 2015 |
Doxorubicin-loaded mesoporous magnetic nanoparticles to induce apoptosis in breast cancer cells.
Topics: Apoptosis; Biocompatible Materials; Breast Neoplasms; Cell Shape; Chitosan; Doxorubicin; Female; Humans; Light; Magnetic Fields; Magnetite Nanoparticles; MCF-7 Cells; Particle Size; Porosity; Scattering, Radiation | 2015 |
Methotrexate-grafted-oligochitosan micelles as drug carriers: synthesis and biological evaluations.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Chitosan; Diffusion; Drug Compounding; Humans; Materials Testing; Methotrexate; Micelles; Nanocapsules; Particle Size; Treatment Outcome | 2015 |
Development and Evaluation of Artesunate-Loaded Chitosan-Coated Lipid Nanocapsule as a Potential Drug Delivery System Against Breast Cancer.
Topics: Antimalarials; Antineoplastic Agents; Artemisinins; Artesunate; Breast Neoplasms; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Stability; Excipients; Female; Humans; Lipids; MCF-7 Cells; Nanocapsules; Nanoparticles; Particle Size; Polymers | 2015 |
Preparation of sodium cholate-based micelles through non-covalent ıbonding interaction and application as oral delivery systems for paclitaxel.
Topics: Acrylates; Animals; Biological Availability; Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Humans; MCF-7 Cells; Micelles; Paclitaxel; Rats; Sodium Cholate | 2016 |
Optimizing the design and in vitro evaluation of bioreactive glucose oxidase-microspheres for enhanced cytotoxicity against multidrug resistant breast cancer cells.
Topics: Adsorption; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chitosan; Dose-Response Relationship, Drug; Drug Compounding; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Emulsions; Gels; Glucose Oxidase; Humans; Hydrogen Peroxide; Lipid Peroxidation; Microscopy, Confocal; Microspheres; Particle Size; Reactive Oxygen Species | 2015 |
Inherently stealthy and highly tumor-selective gold nanoraspberries for photothermal cancer therapy.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; Coculture Techniques; Drug Carriers; Female; Gold; Humans; Metal Nanoparticles; Phototherapy; Surface Plasmon Resonance | 2015 |
Development of (153) Sm-folate-polyethyleneimine-conjugated chitosan nanoparticles for targeted therapy.
Topics: Animals; Breast Neoplasms; Cell Survival; Chitosan; Drug Carriers; Female; Folic Acid; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanoparticles; Organometallic Compounds; Organophosphorus Compounds; Polyethyleneimine; Radiopharmaceuticals; Samarium; Spectroscopy, Fourier Transform Infrared; Tissue Distribution | 2015 |
Characterization and evaluation of metformin-loaded solid lipid nanoparticles for celluar and mitochondrial uptake.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Breast Neoplasms; Calorimetry, Differential Scanning; Chitosan; Chromatography, High Pressure Liquid; Drug Carriers; Female; Humans; Lipids; Male; MCF-7 Cells; Metformin; Mitochondria; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley; Solubility | 2016 |
Functionalized graphene oxide-based thermosensitive hydrogel for magnetic hyperthermia therapy on tumors.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Chitosan; Combined Modality Therapy; Doxorubicin; Female; Glycerophosphates; Graphite; Humans; Hydrogels; Hyperthermia, Induced; Magnetic Fields; MCF-7 Cells; Mice; Polyethyleneimine; Xenograft Model Antitumor Assays | 2015 |
Physicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to MCF-7 breast cancer cells.
Topics: Acetylation; Breast Neoplasms; Cell Adhesion Molecules; Cell Survival; Chitosan; Circular Dichroism; Female; Humans; MCF-7 Cells; MicroRNAs; Microscopy, Confocal; Nanostructures; Particle Size; Receptors, Cell Surface; Surface Plasmon Resonance; Transfection | 2015 |
IR 820 dye encapsulated in polycaprolactone glycol chitosan: Poloxamer blend nanoparticles for photo immunotherapy for breast cancer.
Topics: Breast Neoplasms; Chitosan; Combined Modality Therapy; Glycols; Humans; Immunotherapy; Indocyanine Green; MCF-7 Cells; Nanocapsules; Photochemotherapy; Poloxamer; Polyesters; Radiation-Sensitizing Agents; Reactive Oxygen Species; Treatment Outcome | 2015 |
Free DOX and chitosan-N-arginine conjugate stabilized indocyanine green nanoparticles for combined chemophotothermal therapy.
Topics: Antibiotics, Antineoplastic; Arginine; Breast Neoplasms; Chitosan; Combined Modality Therapy; Doxorubicin; Humans; Hyperthermia, Induced; Indocyanine Green; MCF-7 Cells; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanoparticles; Phototherapy | 2015 |
Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chitosan; Female; Humans; Lactic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Oligosaccharides; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Xenograft Model Antitumor Assays | 2016 |
Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
Topics: Animals; Antibiotics, Antineoplastic; Biotinylation; Breast Neoplasms; Carbocyanines; Cell Survival; Chitosan; Endocytosis; Epirubicin; Humans; Kinetics; Lactic Acid; MCF-7 Cells; Mice, Nude; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Photoelectron Spectroscopy; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties; Xenograft Model Antitumor Assays | 2016 |
Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells.
Topics: Animals; Apoproteins; Apoptosis; Breast Neoplasms; Cattle; Chitosan; Drug Delivery Systems; Female; Humans; Iron; Lactoferrin; MCF-7 Cells; Mice; Moths; Nanoparticles; Receptors, Cell Surface; Silk | 2016 |
Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles.
Topics: 5'-Nucleotidase; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chitosan; Down-Regulation; Female; Flow Cytometry; Gene Expression; Lactic Acid; Mice; Nanoparticles; Real-Time Polymerase Chain Reaction; RNA, Small Interfering | 2016 |
Functionalized graphene oxide-based thermosensitive hydrogel for near-infrared chemo-photothermal therapy on tumor.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Docetaxel; Female; Graphite; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; MCF-7 Cells; Mice; Mice, Inbred BALB C; Oxides; Photochemotherapy; Taxoids; Temperature | 2016 |
Comparison of protein- and polysaccharide-based nanoparticles for cancer therapy: synthesis, characterization, drug release, and interaction with a breast cancer cell line.
Topics: Breast Neoplasms; Chitosan; Drug Delivery Systems; Female; Humans; Hydroxybutyrates; MCF-7 Cells; Nanoparticles; Polyesters; Prohibitins; Serum Albumin | 2017 |
Targeted silencing of Survivin in cancer cells by siRNA loaded chitosan magnetic nanoparticles.
Topics: Breast Neoplasms; Cell Death; Chitosan; Cytoplasm; Drug Resistance, Neoplasm; Female; Gene Silencing; Humans; Hydrogen-Ion Concentration; Inhibitor of Apoptosis Proteins; Magnetite Nanoparticles; MCF-7 Cells; Particle Size; RNA, Small Interfering; Survivin; Time Factors | 2016 |
The impact of the codelivery of drug-siRNA by trimethyl chitosan nanoparticles on the efficacy of chemotherapy for metastatic breast cancer cell line (MDA-MB-231).
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Doxorubicin; Drug Carriers; Drug Liberation; Gene Silencing; HMGA2 Protein; Humans; Nanoparticles; Neoplasm Metastasis; RNA, Small Interfering | 2017 |
Formulation and Cytotoxicity of Ribosome-Inactivating Protein Mirabilis Jalapa L. Nanoparticles Using Alginate-Low Viscosity Chitosan Conjugated with Anti-Epcam Antibodies in the T47D Breast Cancer Cell Line.
Topics: Alginates; Antibodies, Monoclonal; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Proliferation; Chemistry, Pharmaceutical; Chitosan; Epithelial Cell Adhesion Molecule; Female; Flow Cytometry; Glucuronic Acid; Hexuronic Acids; Humans; Mirabilis; Nanoparticles; Particle Size; Plant Extracts; Plant Leaves; Ribosome Inactivating Proteins; Tumor Cells, Cultured; Viscosity | 2016 |
The effects of chitosan/miR-200c nanoplexes on different stages of cancers in breast cancer cell lines.
Topics: Apoptosis; Breast Neoplasms; Chitosan; Drug Carriers; Female; Humans; MCF-7 Cells; MicroRNAs; Neoplasm Staging; Treatment Outcome | 2016 |
Multifunctional near-infrared light-triggered biodegradable micelles for chemo- and photo-thermal combination therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzyl Alcohols; Breast Neoplasms; Chitosan; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Compounding; Drug Stability; Female; Fluorescent Dyes; Humans; Indoles; Infrared Rays; Integrin alphaVbeta3; MCF-7 Cells; Mice, Nude; Micelles; Paclitaxel; Peptides, Cyclic; Photochemotherapy; Photolysis; Propionates; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Movement; Chitosan; Doxorubicin; Drug Delivery Systems; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Heparin; Humans; Nanoparticles; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Receptors, Interleukin-17; RNA, Small Interfering; Serum; Spectroscopy, Fourier Transform Infrared; Wound Healing | 2016 |
Docetaxel-Chitosan nanoparticles for breast cancer treatment: cell viability and gene expression study.
Topics: Antineoplastic Agents, Phytogenic; bcl-2-Associated X Protein; Breast Neoplasms; Cell Survival; Chitosan; Docetaxel; Female; Gene Expression; Humans; MCF-7 Cells; Microscopy, Electron, Scanning; Nanoparticles; Proto-Oncogene Proteins c-bcl-2; Proton Magnetic Resonance Spectroscopy; Real-Time Polymerase Chain Reaction; Spectroscopy, Fourier Transform Infrared; Taxoids | 2016 |
PEGylated chitosan nanoparticles potentiate repurposing of ormeloxifene in breast cancer therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzopyrans; Breast; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Repositioning; Female; Humans; MCF-7 Cells; Nanoparticles; Polyethylene Glycols; Rats, Sprague-Dawley | 2016 |
Folate-Chitosan Nanoparticles Loaded with Ursolic Acid Confer Anti-Breast Cancer Activities in vitro and in vivo.
Topics: Animals; Breast Neoplasms; Cell Proliferation; Cell Survival; Chitosan; Female; Folic Acid; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Mice; Mitochondria; Nanoparticles; Triterpenes; Ursolic Acid; Xenograft Model Antitumor Assays | 2016 |
An in-vivo study for targeted delivery of copper-organic complex to breast cancer using chitosan polymer nanoparticles.
Topics: Animals; Breast Neoplasms; Chitosan; Copper; Drug Delivery Systems; Female; Glycols; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanoparticles; Peptides; Xenograft Model Antitumor Assays | 2016 |
Chitosan-modified PLGA polymeric nanocarriers with better delivery potential for tamoxifen.
Topics: Administration, Topical; Animals; Breast Neoplasms; Chitosan; Drug Carriers; Female; Humans; Lactic Acid; MCF-7 Cells; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Skin Absorption; Tamoxifen | 2016 |
Enhanced Therapeutic Efficacy of Doxorubicin for Breast Cancer Using Chitosan Oligosaccharide-Modified Halloysite Nanotubes.
Topics: Aluminum Silicates; Animals; Breast Neoplasms; Cell Line, Tumor; Chitosan; Clay; Doxorubicin; Humans; Mice; Nanotubes; Oligosaccharides | 2016 |
Multi-cycle chemotherapy with the glycolipid-like polymeric micelles evade cancer stem cell enrichment in breast cancer therapy.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chitosan; Disease Models, Animal; Doxorubicin; Female; Glycolipids; Humans; Mice; Micelles; Neoplastic Stem Cells; Polymers; Spheroids, Cellular; Treatment Outcome; Tumor Cells, Cultured; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2016 |
Targeted delivery of doxorubicin to breast cancer cells by magnetic LHRH chitosan bioconjugated nanoparticles.
Topics: Alginates; Breast Neoplasms; Chitosan; Doxorubicin; Drug Carriers; Ferric Compounds; Glucuronic Acid; Gonadotropin-Releasing Hormone; Hexuronic Acids; Humans; Maleates; MCF-7 Cells; Nanoparticles; Particle Size; Polyethylenes | 2016 |
In Vitro Dose Studies on Chitosan Nanoplexes for microRNA Delivery in Breast Cancer Cells.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chitosan; Culture Media; Cytoplasm; Drug Delivery Systems; Female; Humans; MCF-7 Cells; Mice; MicroRNAs; Nanoparticles; Particle Size; RNA Stability; Time Factors; Transfection | 2017 |
Albumin hybrid nanoparticles loaded with tyrosine kinase A inhibitor GNF-5837 for targeted inhibition of breast cancer cell growth and invasion.
Topics: Albumins; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chitosan; Delayed-Action Preparations; Female; Humans; Mitogen-Activated Protein Kinases; Nanomedicine; Nanoparticles; Neoplasm Invasiveness; Phosphorylation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Signal Transduction | 2016 |
Sequential delivery of therapeutic agents using a rationally designed disulfide-linked glycolipid-like nanocarrier.
Topics: Adsorption; Antineoplastic Agents; Breast Neoplasms; Cell Cycle Checkpoints; Cell Survival; Chitosan; Disulfides; Drug Compounding; Drug Liberation; Female; Gene Transfer Techniques; Humans; Hydrophobic and Hydrophilic Interactions; MCF-7 Cells; Nanoconjugates; Nanomedicine; Oxazines; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Small Interfering; RNAi Therapeutics; Static Electricity; Stearic Acids; Surface Properties; Time Factors; Transfection | 2016 |
Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
Topics: Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Hydrogen-Ion Concentration; Mice; Mice, Inbred BALB C; Nanoparticles; Polyethylene Glycols; Polymers; RNA, Small Interfering | 2016 |
Specific targeting delivery to MUC1 overexpressing tumors by albumin-chitosan nanoparticles conjugated to DNA aptamer.
Topics: Aptamers, Nucleotide; Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Carriers; Female; Humans; MCF-7 Cells; Molecular Targeted Therapy; Mucin-1; Nanoparticles; Paclitaxel; Serum Albumin | 2016 |
CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice.
Topics: 5'-Nucleotidase; Animals; Breast; Breast Neoplasms; Cancer Vaccines; Cell Line, Tumor; Chitosan; Dendritic Cells; Female; Genetic Therapy; Immunotherapy; Lactic Acid; Mice; Mice, Inbred BALB C; Nanoparticles; RNA, Small Interfering; RNAi Therapeutics | 2017 |
Characterization and carboplatin loaded chitosan nanoparticles for the chemotherapy against breast cancer in vitro studies.
Topics: Antineoplastic Agents; Biological Transport; Breast Neoplasms; Carboplatin; Chitosan; Drug Carriers; Drug Liberation; Drug Stability; Hemolysis; Humans; Intracellular Space; MCF-7 Cells; Nanoparticles | 2017 |
Physicochemical characterization of chitosan-hyaluronan-coated solid lipid nanoparticles for the targeted delivery of paclitaxel: a proof-of-concept study in breast cancer cells.
Topics: Breast Neoplasms; Cell Survival; Chitosan; Drug Delivery Systems; Drug Stability; Female; Humans; Hyaluronic Acid; Lipids; MCF-7 Cells; Nanoparticles; Paclitaxel | 2017 |
Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Female; Humans; Nanoparticles; Paclitaxel; Particle Size; Polyethylene Glycols | 2017 |
Artificial Chemical Reporter Targeting Strategy Using Bioorthogonal Click Reaction for Improving Active-Targeting Efficiency of Tumor.
Topics: Azides; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Chitosan; Click Chemistry; Female; Humans; Lung Neoplasms; Nanoparticles | 2017 |
Potential of amphiphilic graft copolymer α-tocopherol succinate-g-carboxymethyl chitosan in modulating the permeability and anticancer efficacy of tamoxifen.
Topics: alpha-Tocopherol; Animals; Antineoplastic Agents; Biological Availability; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Chitosan; Drug Carriers; Female; Humans; Hydrophobic and Hydrophilic Interactions; MCF-7 Cells; Micelles; Permeability; Polymers; Rats; Rats, Sprague-Dawley; Tamoxifen | 2017 |
Simplifying Nucleic Acid Amplification from Whole Blood with Direct Polymerase Chain Reaction on Chitosan Microparticles.
Topics: Breast Neoplasms; Chitosan; DNA; Female; Humans; MCF-7 Cells; Nucleic Acid Amplification Techniques; Particle Size; Plasmids; Real-Time Polymerase Chain Reaction; Silicon Dioxide; Tumor Cells, Cultured | 2017 |
A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
Topics: Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Fatty Alcohols; Female; Glycolipids; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Mice; Mice, Nude; Micelles; Nanoparticles; Ovarian Neoplasms; Schiff Bases | 2017 |
Electrochemical detection of a breast cancer susceptible gene using cDNA immobilized chitosan-co-polyaniline electrode.
Topics: Aniline Compounds; Breast Neoplasms; Calibration; Chitosan; DNA, Complementary; Electrochemistry; Electrodes; Female; Genetic Predisposition to Disease; Humans; Microscopy, Atomic Force; Molecular Structure; Spectroscopy, Fourier Transform Infrared | 2009 |
Suppression of metastasis of human breast cancer cells by chitosan oligosaccharides.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Movement; Chelating Agents; Chitosan; Female; Humans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Metastasis | 2009 |
Synthesis of 6-N,N,N-trimethyltriazole chitosan via "click chemistry" and evaluation for gene delivery.
Topics: Breast Neoplasms; Cell Proliferation; Cells, Cultured; Chitosan; DNA; Drug Delivery Systems; Female; Gene Transfer Techniques; Green Fluorescent Proteins; Humans; Kidney; Nanoparticles; Plasmids; Transfection; Triazoles | 2009 |
The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia.
Topics: Alginates; Animals; Breast Neoplasms; Chitosan; Female; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogels; Hyperthermia, Induced; Magnetics; Mice; Mice, Nude; Mice, SCID; Nanoparticles; Solvents; Transplantation, Heterologous | 2010 |
Role of the pharmaceutical excipients in the tamoxifen activity on MCF-7 and vero cell cultures.
Topics: Alginates; Animals; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Chitosan; Chlorocebus aethiops; Excipients; Glucuronic Acid; Hexuronic Acids; Humans; Particle Size; Tamoxifen; Vero Cells | 2009 |
A novel methotrexate delivery system based on chitosan-methotrexate covalently conjugated nanoparticles.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; Crystallization; Diffusion; Humans; Macromolecular Substances; Materials Testing; Methotrexate; Molecular Conformation; Nanocapsules; Nanomedicine; Particle Size; Surface Properties | 2009 |
Preparation and in-vitro/in-vivo evaluation of surface-modified poly (lactide-co-glycolide) fluorescent nanoparticles.
Topics: Animals; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Chitosan; Coumarins; Drug Carriers; Female; Flow Cytometry; Fluorescence; Lactic Acid; Mice; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectrometry, Fluorescence; Surface Properties; Technology, Pharmaceutical; Thiazoles; Tissue Distribution | 2010 |
In vitro silencing effect of chitosan nanoplexes containing siRNA expressing vector targeting VEGF in breast cancer cell lines.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; Chromatography, Gel; Enzyme-Linked Immunosorbent Assay; Enzymes; Female; Gene Silencing; Green Fluorescent Proteins; Humans; Microscopy, Electron, Transmission; Plasmids; RNA, Small Interfering; Serum; Transfection; Vascular Endothelial Growth Factor A | 2010 |
Chitosan hydrogel for localized gene silencing.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Gene Silencing; Humans; Hydrogels; Melanoma; Mice; Mice, Nude; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2011 |
Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chitosan; Female; Humans; Immunotherapy; Indocyanine Green; Lasers; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Tomography, X-Ray Computed | 2011 |
Synthesis and in vitro studies of biodegradable thiolated chitosan hydrogels for breast cancer therapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Stability; Hydrogels; Letrozole; Nanoparticles; Nitriles; Sulfhydryl Compounds; Tensile Strength; Triazoles | 2011 |
Polyelectrolyte microcapsules with entrapped multicellular tumor spheroids as a novel tool to study the effects of photodynamic therapy.
Topics: Alginates; Biocompatible Materials; Breast Neoplasms; Capsules; Cell Culture Techniques; Cell Line, Tumor; Chitosan; Chlorophyllides; Female; Humans; Materials Testing; Models, Biological; Particle Size; Photochemotherapy; Photosensitizing Agents; Porphyrins; Spheroids, Cellular; Static Electricity | 2011 |
Sustained release optimized formulation of anastrozole-loaded chitosan microspheres: in vitro and in vivo evaluation.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Area Under Curve; Breast Neoplasms; Chitosan; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Diffusion; Glutaral; Humans; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Microspheres; Nitriles; Particle Size; Polymers; Spectroscopy, Fourier Transform Infrared; Triazoles | 2011 |
In vivo tumor accumulation of nanoparticles formed by ionic interaction of glycol chitosan and fatty acid ethyl ester.
Topics: Animals; Biological Transport, Active; Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Fatty Acids; Female; Humans; Ions; Mice; Mice, Nude; Microscopy, Electron, Transmission; Nanoparticles; Nanotechnology; Neoplasm Transplantation; Permeability; Spectroscopy, Fourier Transform Infrared; Static Electricity; Transplantation, Heterologous | 2011 |
Novel polymer coupled lipid nanoparticle of paclitaxel with synergistic enhanced efficacy against cancer.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chitosan; Humans; Lipids; Nanocapsules; Paclitaxel; Treatment Outcome | 2011 |
Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy.
Topics: Animals; Biocompatible Materials; Breast Neoplasms; Cattle; Cell Line, Tumor; Chitosan; Drug Carriers; Female; Humans; Hydrogen-Ion Concentration; Materials Testing; Nanospheres; Serum Albumin, Bovine; Silanes; Silicon Dioxide; Tumor Necrosis Factor-alpha | 2011 |
Chitosan derivatives inhibit cell proliferation and induce apoptosis in breast cancer cells.
Topics: Apoptosis; Blotting, Western; Breast Neoplasms; Cell Proliferation; Chitosan; Female; Fibroblast Growth Factor 2; Humans; Mitogen-Activated Protein Kinases; ras Proteins; Signal Transduction; Tumor Cells, Cultured | 2011 |
Repair and reconstruction of a resected tumor defect using a composite of tissue flap-nanotherapeutic-silk fibroin and chitosan scaffold.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chitosan; Emodin; Female; Humans; Nanoparticles; Rats; Rats, Nude; Silk; Surgical Flaps; Tensile Strength; Tissue Scaffolds; Xenograft Model Antitumor Assays | 2011 |
In situ forming chitosan hydrogels prepared via ionic/covalent co-cross-linking.
Topics: Animals; Biocompatible Materials; Biodegradation, Environmental; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chitosan; Cross-Linking Reagents; Drug Carriers; Elastic Modulus; Female; Glycerol; Hydrogels; Hydrogen-Ion Concentration; Ions; Iridoid Glycosides; Iridoids; Male; Mice; Microscopy, Electron, Scanning; Muramidase; Porosity; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared | 2011 |
Conjugated oligoelectrolyte-polyhedral oligomeric silsesquioxane loaded pH-responsive nanoparticles for targeted fluorescence imaging of cancer cell nucleus.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Chitosan; Female; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Mice; Molecular Imaging; Nanoparticles; NIH 3T3 Cells; Organosilicon Compounds; Polyethylene Glycols; Spectrometry, Fluorescence | 2011 |
Rose bengal-grafted biodegradable microcapsules: singlet-oxygen generation and cancer-cell incapacitation.
Topics: Alginates; Breast Neoplasms; Capsules; Chitosan; Drug Delivery Systems; Electron Spin Resonance Spectroscopy; Female; Glucuronic Acid; Hexuronic Acids; Humans; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanotechnology; Rose Bengal; Singlet Oxygen; Spectrophotometry, Infrared | 2011 |
Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells.
Topics: Breast Neoplasms; Chitosan; Doxorubicin; Drug Carriers; ErbB Receptors; Female; Humans; Nanoparticles; Oligodeoxyribonucleotides, Antisense; Thioglycolates | 2011 |
Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Chemistry, Physical; Chitosan; Doxorubicin; Female; Humans; Nanoconjugates; Ovarian Neoplasms; Particle Size; Receptor, ErbB-2; Trastuzumab | 2011 |
Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
Topics: Acetylation; Breast Neoplasms; Cell Line, Tumor; Chitosan; Female; Humans; Lipids; Luciferases; Molecular Weight; Nanoparticles; Nucleic Acid Conformation; Particle Size; Peptides; Permeability; Phosphorylation; RNA Interference; RNA, Small Interfering; Transfection | 2012 |
α-Tocopherol succinate-modified chitosan as a micellar delivery system for paclitaxel: preparation, characterization and in vitro/in vivo evaluations.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Female; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Magnetic Resonance Spectroscopy; Male; Mice; Micelles; Microscopy, Electron, Transmission; Paclitaxel; Particle Size; Rabbits; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical; Tocopherols; Uterine Cervical Neoplasms | 2012 |
Synthesis and characterization of amphiphilic chitosan derivatives as a nano-carrier for paclitaxel delivery.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Deoxycholic Acid; Drug Carriers; Drug Compounding; Epoxy Compounds; Female; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kinetics; Microscopy, Confocal; Nanoparticles; Nanotechnology; Paclitaxel; Particle Size; Propanols; Quaternary Ammonium Compounds; Solubility; Surface-Active Agents; Technology, Pharmaceutical | 2011 |
Supramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Diffusion; Female; Humans; Micelles; Nanocapsules; Paclitaxel; Polyethylene Glycols; Vitamin E | 2011 |
Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Calorimetry, Differential Scanning; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Chromatography, Gel; Curcumin; Down-Regulation; Doxorubicin; Drug Carriers; Drug Combinations; Drug Compounding; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enbucrilate; Female; Humans; Nanoparticles; Nanotechnology; Particle Size; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical | 2012 |
Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan-folic acid micelles.
Topics: Absorbable Implants; Breast Neoplasms; Cell Membrane; Cell Nucleus; Chitosan; Drug Carriers; Female; Folic Acid; Humans; Micelles; Microscopy, Fluorescence; Paclitaxel; Rhodamines; Solubility; Tumor Cells, Cultured | 2012 |
Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONs.
Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Cell Line, Tumor; Chemical Phenomena; Chitosan; Disease Models, Animal; Drug Design; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Mice, Transgenic; Neoplasm Metastasis; Polyethylene Glycols; Receptor, ErbB-2; Substrate Specificity | 2012 |
5-flourouracil loaded N,O-carboxymethyl chitosan nanoparticles as an anticancer nanomedicine for breast cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Blood Coagulation Tests; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Female; Flow Cytometry; Fluorouracil; Hemolysis; Humans; Mice; Nanoparticles; Particle Size | 2012 |
Iodinated photosensitizing chitosan: self-assembly into tumor-homing nanoparticles with enhanced singlet oxygen generation.
Topics: Animals; Breast; Breast Neoplasms; Cell Line, Tumor; Chitosan; Chlorophyllides; Drug Delivery Systems; Female; Halogenation; HeLa Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Porphyrins; Singlet Oxygen | 2012 |
Folate conjugated chitosan grafted thiazole orange derivative with high targeting for early breast cancer cells diagnosis.
Topics: Amines; Animals; Benzothiazoles; Breast Neoplasms; Cattle; Chitosan; Drug Design; Early Detection of Cancer; Fluorescent Dyes; Folate Receptors, GPI-Anchored; Folic Acid; Humans; MCF-7 Cells; Quinolines; Serum Albumin, Bovine; Temperature | 2012 |
In vivo studies of octreotide-modified N-octyl-O, N-carboxymethyl chitosan micelles loaded with doxorubicin for tumor-targeted delivery.
Topics: Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Chemistry, Pharmaceutical; Chitosan; Doxorubicin; Drug Carriers; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Octreotide; Optical Imaging; Particle Size; Technology, Pharmaceutical; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
In vitro evaluation on novel modified chitosan for targeted antitumor drug delivery.
Topics: Antineoplastic Agents; Breast Neoplasms; Chitosan; Drug Carriers; Female; Folic Acid; Humans; MCF-7 Cells; Micelles; Paclitaxel; Polymers | 2013 |
Characterization and evaluation of chitosan matrix for in vitro growth of MCF-7 breast cancer cell lines.
Topics: Biocompatible Materials; Breast Neoplasms; Cell Adhesion; Cell Culture Techniques; Cell Division; Cell Line, Tumor; Cell Survival; Chitosan; Humans; Materials Testing; Surface Properties; Tissue Engineering | 2004 |
Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen.
Topics: Antineoplastic Agents; Apoptosis; Biocompatible Materials; Breast Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Materials Testing; Membranes, Artificial; Tamoxifen; Tissue Engineering | 2005 |
Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases. I: Formulation and in vitro characterization.
Topics: Antineoplastic Agents; Breast Neoplasms; Chemistry, Pharmaceutical; Chitosan; Drug Stability; Freeze Drying; Hydrogen-Ion Concentration; In Vitro Techniques; Injections; Lymphatic Metastasis; Mitoxantrone; Nanotubes; Serum Albumin, Bovine; Solubility; Sterilization; Time Factors | 2006 |
Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chitosan; Humans; Infusion Pumps; Mice; Nanoparticles; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; rhoA GTP-Binding Protein; RNA, Small Interfering | 2006 |
The efficacy of methotrexate-impregnated hydroxyapatite composites on human mammary carcinoma cells.
Topics: Alginates; Antimetabolites, Antineoplastic; Biocompatible Materials; Breast Neoplasms; Calcium Sulfate; Chitosan; Drug Carriers; Drug Combinations; Humans; Hydroxyapatites; In Vitro Techniques; Methotrexate; Spectroscopy, Fourier Transform Infrared; Tumor Cells, Cultured | 2007 |
A novel nanoparticle formulation for sustained paclitaxel delivery.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Membrane Permeability; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Emulsions; Female; Glycerides; Humans; Inhibitory Concentration 50; Kinetics; Microscopy, Electron, Transmission; Nanoparticles; Paclitaxel; Particle Size; Solubility; Surface Properties; Technology, Pharmaceutical; Time Factors | 2008 |